Exact Mass: 410.2825

Exact Mass Matches: 410.2825

Found 476 metabolites which its exact mass value is equals to given mass value 410.2825, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

gamma-Tocotrienol

(2R)-3,4-Dihydro-2,7,8-trimethyl-2-[(3E,7E)-4,8,12-trimethyl-3,7,11-tridecatrien-1-yl]-2H-1-benzopyran-6-ol

C28H42O2 (410.3185)


gamma-Tocotrienol, also known as 7,8-dimethyltocotrienol, belongs to the class of organic compounds known as tocotrienols. These are vitamin E derivatives containing an unsaturated trimethyltrideca-3,7,11-trien-1-yl chain attached to the C6 atom of a benzopyran ring system. They differ from tocopherols that contain a saturated trimethyltridecyl chain. Thus, gamma-tocotrienol is considered to be a quinone lipid molecule. gamma-Tocotrienol is a very hydrophobic molecule, practically insoluble (in water), and relatively neutral. gamma-Tocotrienol targets cancer cells by inhibiting Id1, a key cancer-promoting protein. gamma-Tocotrienol was shown to trigger cell apoptosis and well as anti-proliferation of cancer cells. This mechanism was also observed in separate prostate cancer and melanoma cell line studies. Constituent of palm oil. Nutriceutical with anticancer props. and a positive influence on the blood lipid profile. gamma-Tocotrienol is found in many foods, some of which are rye, corn, rosemary, and common grape. Acquisition and generation of the data is financially supported in part by CREST/JST. γ-Tocotrienol is an active form of vitamin E. γ-tocotrienol reverses the multidrug resistance (MDR) of breast cancer cells through the signaling pathway of NF-κB and P-gp. γ-Tocotrienol is also a novel radioprotector agent, can mitigate bone marrow radiation damage during targeted radionuclide treatment[1][2][3]. γ-Tocotrienol is an active form of vitamin E. γ-tocotrienol reverses the multidrug resistance (MDR) of breast cancer cells through the signaling pathway of NF-κB and P-gp. γ-Tocotrienol is also a novel radioprotector agent, can mitigate bone marrow radiation damage during targeted radionuclide treatment[1][2][3].

   

beta-tocotrienol

(2R)-2,5,8-Trimethyl-2-[(3E,7E)-4,8,12-trimethyltrideca-3,7,11-trien-1-yl]-3,4-dihydro-2H-1-benzopyran-6-ol

C28H42O2 (410.3185)


   

Sterol 3-beta-D-glucoside

Sterol 3-beta-D-glucoside

C23H38O6 (410.2668)


   

LysoPA(16:0/0:0)

1-Palmitoyl-lysophosphatidic acid, sodium salt, (R)-isomer

C19H39O7P (410.2433)


LysoPA(16:0/0:0) is a lysophosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. Fatty acids containing 16 and 18 carbons are the most common. Lysophosphatidic acid is the simplest possible glycerophospholipid. It is the biosynthetic precursor of phosphatidic acid. Although it is present at very low levels only in animal tissues, it is extremely important biologically, influencing many biochemical processes. In particular, lysophosphatidic acid is an intercellular lipid mediator with growth factor-like activities, and is rapidly produced and released from activated platelets to influence target cells. 1-Palmitoyl lysophosphatidic acid is the major component of lysophosphatidic acid (LPA) in plasma, and is in a reduced ratio in individuals with gynecological cancers (PMID 11585410). LPA is a pluripotent lipid mediator controlling growth, motility, and differentiation, that has a strong influence on the chemotaxis and ultrastructure of human neutrophils (PMID 7416233). In serum and plasma, LPA is mainly converted from lysophospholipids, whereas in platelets and some cancer cells it is converted from phosphatidic acid. In each pathway, at least two phospholipase activities are required: phospholipase A1 (PLA1)/PLA2 plus lysophospholipase D (lysoPLD) activities are involved in the first pathway and phospholipase D (PLD) plus PLA1/PLA2 activities are involved in the second pathway. (PMID 15271293). Lysopa(16:0/0:0), also known as 1-palmitoyl lysophosphatidic acid or 1-hexadecanoyl-sn-glycero-3-phosphate, is a member of the class of compounds known as 1-acylglycerol-3-phosphates. 1-acylglycerol-3-phosphates are lysophosphatidic acids where the glycerol is esterified with a fatty acid at O-1 position. Thus, lysopa(16:0/0:0) is considered to be a glycerophosphate lipid molecule. Lysopa(16:0/0:0) is practically insoluble (in water) and a moderately acidic compound (based on its pKa). Lysopa(16:0/0:0) can be found in a number of food items such as alfalfa, soy bean, banana, and barley, which makes lysopa(16:0/0:0) a potential biomarker for the consumption of these food products. Lysopa(16:0/0:0) can be found primarily throughout all human tissues. Lysopa(16:0/0:0) exists in all living species, ranging from bacteria to humans. In humans, lysopa(16:0/0:0) is involved in several metabolic pathways, some of which include cardiolipin biosynthesis CL(16:0/18:1(11Z)/18:0/18:1(9Z)), cardiolipin biosynthesis CL(16:0/16:1(9Z)/16:1(9Z)/16:0), cardiolipin biosynthesis CL(16:0/20:4(5Z,8Z,11Z,14Z)/18:0/20:4(5Z,8Z,11Z,14Z)), and cardiolipin biosynthesis CL(16:0/18:1(11Z)/18:0/18:1(11Z)). Lysopa(16:0/0:0) is also involved in several metabolic disorders, some of which include de novo triacylglycerol biosynthesis TG(16:0/24:0/20:4(8Z,11Z,14Z,17Z)), de novo triacylglycerol biosynthesis TG(16:0/22:2(13Z,16Z)/22:0), de novo triacylglycerol biosynthesis TG(16:0/15:0/18:3(9Z,12Z,15Z)), and de novo triacylglycerol biosynthesis TG(16:0/15:0/24:0).

   

Norethindrone enanthate

Norethindrone enanthate; Norethisterone enanthate; 17alpha-Ethynyl-17beta-heptanoyloxy-4-estren-3-one

C27H38O3 (410.2821)


D012102 - Reproductive Control Agents > D003270 - Contraceptive Agents Same as: D08285

   

2,3-dimethyl-6-geranylgeranyl-1,4-benzoquinol

2,3-dimethyl-6-geranylgeranyl-1,4-benzoquinol

C28H42O2 (410.3185)


   

epsilon-Tocopherol

(2R)-3,4-dihydro-2,5,8-trimethyl-2-[(3E,7E)-4,8,12-trimethyl-3,7,11-tridecatrienyl]-2H-1-benzopyran-6-ol

C28H42O2 (410.3185)


Isolated from wheat bran oil. epsilon-Tocopherol is found in many foods, some of which are rye, coconut, rosemary, and fennel. epsilon-Tocopherol is found in american cranberry. epsilon-Tocopherol is isolated from wheat bran oi

   

(3beta,22E,24R)-3-Hydroxyergosta-5,8,22-trien-7-one

14-[(3E)-5,6-dimethylhept-3-en-2-yl]-5-hydroxy-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadeca-1(10),7-dien-9-one

C28H42O2 (410.3185)


(3beta,22E,24R)-3-Hydroxyergosta-5,8,22-trien-7-one is found in mushrooms. (3beta,22E,24R)-3-Hydroxyergosta-5,8,22-trien-7-one is a constituent of Grifola frondosa (maitake) Constituent of Grifola frondosa (maitake). (3beta,22E,24R)-3-Hydroxyergosta-5,8,22-trien-7-one is found in mushrooms.

   

5,8-Epoxy-5,8-dihydro-10'-apo-b,y-carotene-3,10'-diol

2-[(2Z,4E,6E,8E,10E,12E)-14-hydroxy-6,11-dimethyltetradeca-2,4,6,8,10,12-hexaen-2-yl]-4,4,7a-trimethyl-2,4,5,6,7,7a-hexahydro-1-benzofuran-6-ol

C27H38O3 (410.2821)


5,8-Epoxy-5,8-dihydro-10-apo-b,y-carotene-3,10-diol is found in citrus. 5,8-Epoxy-5,8-dihydro-10-apo-b,y-carotene-3,10-diol is isolated from Persea americana (avocado) and from Valencia orange juice. Isolated from Persea americana (avocado) and from Valencia orange juice. 5,8-Epoxy-5,8-dihydro-10-apo-b,y-carotene-3,10-diol is found in citrus and fruits.

   

5,6-Epoxy-5,6-dihydro-10'-apo-b,y-carotene-3,10'-diol

6-[(1E,3Z,5E,7E,9E,11Z,13Z)-15-hydroxy-3,7,12-trimethylpentadeca-1,3,5,7,9,11,13-heptaen-1-yl]-1,5,5-trimethyl-7-oxabicyclo[4.1.0]heptan-3-ol

C27H38O3 (410.2821)


5,6-Epoxy-5,6-dihydro-10-apo-b,y-carotene-3,10-diol is found in pomes. 5,6-Epoxy-5,6-dihydro-10-apo-b,y-carotene-3,10-diol is isolated from the peel of the ripe Golden Delicious apple. 5,6-Epoxy-5,6-dihydro-10-apo-b,y-carotene-3,10-diol isa metabolite of JVG-51D in the mature fruit. Isolated from the peel of the ripe Golden Delicious apple. Prob. a metabolite of JVG-51D in the mature fruit. 5,6-Epoxy-5,6-dihydro-10-apo-b,y-carotene-3,10-diol is found in pomes.

   

LysoPA(0:0/16:0)

[2-(hexadecanoyloxy)-3-hydroxypropoxy]phosphonic acid

C19H39O7P (410.2433)


LysoPA(0:0/16:0) is a lysophosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. Fatty acids containing 16 and 18 carbons are the most common. Lysophosphatidic acid is the simplest possible glycerophospholipid. It is the biosynthetic precursor of phosphatidic acid. Although it is present at very low levels only in animal tissues, it is extremely important biologically, influencing many biochemical processes. In particular, lysophosphatidic acid is an intercellular lipid mediator with growth factor-like activities, and is rapidly produced and released from activated platelets to influence target cells. 1-Palmitoyl lysophosphatidic acid is the major component of lysophosphatidic acid (LPA) in plasma, and is in a reduced ratio in individuals with gynecological cancers (PMID 11585410). LPA is a pluripotent lipid mediator controlling growth, motility, and differentiation, that has a strong influence on the chemotaxis and ultrastructure of human neutrophils (PMID 7416233). In serum and plasma, LPA is mainly converted from lysophospholipids, whereas in platelets and some cancer cells it is converted from phosphatidic acid. In each pathway, at least two phospholipase activities are required: phospholipase A1 (PLA1)/PLA2 plus lysophospholipase D (lysoPLD) activities are involved in the first pathway and phospholipase D (PLD) plus PLA1/PLA2 activities are involved in the second pathway. (PMID 15271293).

   

(6alpha,22E)-6-Hydroxy-4,7,22-ergostatrien-3-one

14-[(3E)-5,6-dimethylhept-3-en-2-yl]-8-hydroxy-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadeca-6,9-dien-5-one

C28H42O2 (410.3185)


(6beta,22E)-6-Hydroxy-4,7,22-ergostatrien-3-one is found in mushrooms. (6beta,22E)-6-Hydroxy-4,7,22-ergostatrien-3-one is a metabolite of Ganoderma lucidum (reishi).

   

N-Oleoyl Glutamine

4-(C-Hydroxycarbonimidoyl)-2-[(1-hydroxyoctadec-9-en-1-ylidene)amino]butanoate

C23H42N2O4 (410.3144)


N-oleoyl glutamine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is an Oleic acid amide of Glutamine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Oleoyl Glutamine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Oleoyl Glutamine is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.

   

(2R)-2,5,8-Trimethyl-2-(4,8,12-trimethyltrideca-3,7,11-trienyl)-3,4-dihydrochromen-6-ol

2,5,8-trimethyl-2-(4,8,12-trimethyltrideca-3,7,11-trien-1-yl)-3,4-dihydro-2H-1-benzopyran-6-ol

C28H42O2 (410.3185)


   

(2R)-2,7,8-Trimethyl-2-(4,8,12-trimethyltrideca-3,7,11-trienyl)-3,4-dihydrochromen-6-ol

2,7,8-trimethyl-2-(4,8,12-trimethyltrideca-3,7,11-trien-1-yl)-3,4-dihydro-2H-1-benzopyran-6-ol

C28H42O2 (410.3185)


   

2-Dicyclohexylphosphino-2',6'-dimethoxybiphenyl

dicyclohexyl({2,6-dimethoxy-[1,1-biphenyl]-2-yl})phosphane

C26H35O2P (410.2375)


   

2-Pyridinemethanamine, N-((4-(1,4,8,11-tetraazacyclotetradec-1-ylmethyl)phenyl)methyl)-

[(pyridin-2-yl)methyl]({4-[(1,4,8,11-tetraazacyclotetradecan-1-yl)methyl]phenyl}methyl)amine

C24H38N6 (410.3158)


   

Arlacel A

6-hydroxy-hexahydrofuro[3,2-b]furan-3-yl octadec-9-enoate

C24H42O5 (410.3032)


   

Vesatolimod

4-amino-2-butoxy-8-({3-[(pyrrolidin-1-yl)methyl]phenyl}methyl)-5,6,7,8-tetrahydropteridin-6-one

C22H30N6O2 (410.243)


D000890 - Anti-Infective Agents > D000998 - Antiviral Agents C308 - Immunotherapeutic Agent > C2139 - Immunostimulant C254 - Anti-Infective Agent > C281 - Antiviral Agent

   

Norethisterone enanthate

14-ethynyl-15-methyl-5-oxotetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-14-yl heptanoate

C27H38O3 (410.2821)


   

1,25-Dihydroxy-16-ene-23-yne-vitamin D3

5-{2-[3-(6-hydroxy-6-methylhept-4-yn-2-yl)-3a-methyl-3a,4,5,6,7,7a-hexahydro-1H-inden-7-ylidene]ethylidene}-4-methylidenecyclohexane-1,3-diol

C27H38O3 (410.2821)


   

tilorone

2,7-bis[2-(diethylamino)ethoxy]-9H-fluoren-9-one

C25H34N2O3 (410.2569)


   

MG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/0:0)

(2S)-2,3-Dihydroxypropyl (5S,6Z,8E,10E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid

C23H38O6 (410.2668)


MG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).

   

MG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/0:0)

(2S)-2,3-Dihydroxypropyl (5R,6E,8Z,11Z,15S)-5,15-dihydroxyicosa-6,8,11,13-tetraenoic acid

C23H38O6 (410.2668)


MG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).

   

MG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/0:0)

(2S)-2,3-Dihydroxypropyl (5S,6S,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoic acid

C23H38O6 (410.2668)


MG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).

   

MG(0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0)

1,3-Dihydroxypropan-2-yl (5R,6Z,8E,10E,12S,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid

C23H38O6 (410.2668)


MG(0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).

   

MG(0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0)

1,3-Dihydroxypropan-2-yl (5S,6E,8Z,11Z,15R)-5,15-dihydroxyicosa-6,8,11,13-tetraenoic acid

C23H38O6 (410.2668)


MG(0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).

   

MG(0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0)

1,3-Dihydroxypropan-2-yl (5R,6R,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoic acid

C23H38O6 (410.2668)


MG(0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).

   

DG(2:0/18:2(10E,12Z)+=O(9)/0:0)

(2S)-1-(Acetyloxy)-3-hydroxypropan-2-yl (10E,12Z)-9-oxooctadeca-10,12-dienoic acid

C23H38O6 (410.2668)


DG(2:0/18:2(10E,12Z)+=O(9)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/18:2(10E,12Z)+=O(9)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(18:2(10E,12Z)+=O(9)/2:0/0:0)

(2S)-2-(Acetyloxy)-3-hydroxypropyl (10E,12Z)-9-oxooctadeca-10,12-dienoic acid

C23H38O6 (410.2668)


DG(18:2(10E,12Z)+=O(9)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(18:2(10E,12Z)+=O(9)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/0:0/18:2(10E,12Z)+=O(9))

(2R)-3-(Acetyloxy)-2-hydroxypropyl (10E,12Z)-9-oxooctadeca-10,12-dienoic acid

C23H38O6 (410.2668)


DG(2:0/0:0/18:2(10E,12Z)+=O(9)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(18:2(10E,12Z)+=O(9)/0:0/2:0)

(2S)-3-(Acetyloxy)-2-hydroxypropyl (10E,12Z)-9-oxooctadeca-10,12-dienoic acid

C23H38O6 (410.2668)


DG(18:2(10E,12Z)+=O(9)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/18:2(9Z,11E)+=O(13)/0:0)

(2S)-1-(Acetyloxy)-3-hydroxypropan-2-yl (9Z,11E)-13-oxooctadeca-9,11-dienoic acid

C23H38O6 (410.2668)


DG(2:0/18:2(9Z,11E)+=O(13)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/18:2(9Z,11E)+=O(13)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(18:2(9Z,11E)+=O(13)/2:0/0:0)

(2S)-2-(Acetyloxy)-3-hydroxypropyl (9Z,11E)-13-oxooctadeca-9,11-dienoic acid

C23H38O6 (410.2668)


DG(18:2(9Z,11E)+=O(13)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(18:2(9Z,11E)+=O(13)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/0:0/18:2(9Z,11E)+=O(13))

(2R)-3-(Acetyloxy)-2-hydroxypropyl (9Z,11E)-13-oxooctadeca-9,11-dienoic acid

C23H38O6 (410.2668)


DG(2:0/0:0/18:2(9Z,11E)+=O(13)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(18:2(9Z,11E)+=O(13)/0:0/2:0)

(2S)-3-(Acetyloxy)-2-hydroxypropyl (9Z,11E)-13-oxooctadeca-9,11-dienoic acid

C23H38O6 (410.2668)


DG(18:2(9Z,11E)+=O(13)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/18:3(10,12,15)-OH(9)/0:0)

(2S)-1-(Acetyloxy)-3-hydroxypropan-2-yl (10E,12E,15E)-9-hydroxyoctadeca-10,12,15-trienoic acid

C23H38O6 (410.2668)


DG(2:0/18:3(10,12,15)-OH(9)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/18:3(10,12,15)-OH(9)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(18:3(10,12,15)-OH(9)/2:0/0:0)

(2S)-2-(Acetyloxy)-3-hydroxypropyl (10E,12E,15E)-9-hydroxyoctadeca-10,12,15-trienoic acid

C23H38O6 (410.2668)


DG(18:3(10,12,15)-OH(9)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(18:3(10,12,15)-OH(9)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/0:0/18:3(10,12,15)-OH(9))

(2R)-3-(Acetyloxy)-2-hydroxypropyl (10E,12E,15E)-9-hydroxyoctadeca-10,12,15-trienoic acid

C23H38O6 (410.2668)


DG(2:0/0:0/18:3(10,12,15)-OH(9)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(18:3(10,12,15)-OH(9)/0:0/2:0)

(2S)-3-(Acetyloxy)-2-hydroxypropyl (10E,12E,15E)-9-hydroxyoctadeca-10,12,15-trienoic acid

C23H38O6 (410.2668)


DG(18:3(10,12,15)-OH(9)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/18:3(9,11,15)-OH(13)/0:0)

(2S)-1-(Acetyloxy)-3-hydroxypropan-2-yl (9E,11E,15E)-13-hydroxyoctadeca-9,11,15-trienoic acid

C23H38O6 (410.2668)


DG(2:0/18:3(9,11,15)-OH(13)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/18:3(9,11,15)-OH(13)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(18:3(9,11,15)-OH(13)/2:0/0:0)

(2S)-2-(Acetyloxy)-3-hydroxypropyl (9E,11E,15E)-13-hydroxyoctadeca-9,11,15-trienoic acid

C23H38O6 (410.2668)


DG(18:3(9,11,15)-OH(13)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(18:3(9,11,15)-OH(13)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/0:0/18:3(9,11,15)-OH(13))

(2R)-3-(Acetyloxy)-2-hydroxypropyl (9E,11E,15E)-13-hydroxyoctadeca-9,11,15-trienoic acid

C23H38O6 (410.2668)


DG(2:0/0:0/18:3(9,11,15)-OH(13)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(18:3(9,11,15)-OH(13)/0:0/2:0)

(2S)-3-(Acetyloxy)-2-hydroxypropyl (9E,11E,15E)-13-hydroxyoctadeca-9,11,15-trienoic acid

C23H38O6 (410.2668)


DG(18:3(9,11,15)-OH(13)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

Sinensiaxanthin

6-[(1E,3E,5E,7E,9E,11E,13E)-15-hydroxy-3,7,12-trimethylpentadeca-1,3,5,7,9,11,13-heptaen-1-yl]-1,5,5-trimethyl-7-oxabicyclo[4.1.0]heptan-3-ol

C27H38O3 (410.2821)


Sinensiaxanthin is a member of the class of compounds known as sesterterpenoids. Sesterterpenoids are terpenes composed of five consecutive isoprene units. Sinensiaxanthin is practically insoluble (in water) and an extremely weak acidic compound (based on its pKa). Sinensiaxanthin can be found in apple and sweet orange, which makes sinensiaxanthin a potential biomarker for the consumption of these food products.

   
   

Azafrinal

(5R,6R)-5,6-Dihydro-5,6-dihydroxy-10-apo-beta,psi-carotenal

C27H38O3 (410.2821)


   

Dehydrorobustol A

Dehydrorobustol A

C26H34O4 (410.2457)


   

(+)-Isojaspic acid

(+)-Isojaspic acid

C27H38O3 (410.2821)


   

Sargachromanol N

Sargachromanol N

C27H38O3 (410.2821)


   

Gerronemin E

Gerronemin E

C26H34O4 (410.2457)


   

Dehydrograviphane

Dehydrograviphane

C26H34O4 (410.2457)


   

(+)-Makassaric acid

3-{[(14beta)-8,13-dimethylpodocarp-12-en-14-yl]methyl}-4-hydroxybenzoic acid

C27H38O3 (410.2821)


A meroterpenoid isolated from the marine sponge Acanthodendrilla sp. It exhibits inhibitory activity against the enzyme mitogen-activated protein kinase-activated protein kinase 2 (EC 2.7.11.1).

   

Betaenone F

Betaenone F

C23H38O6 (410.2668)


   

Rhizopogone

Rhizopogone

C26H34O4 (410.2457)


   

Strongylophorin 2

Strongylophorin 2

C26H34O4 (410.2457)


   

Kermadecin H

Kermadecin H

C26H34O4 (410.2457)


   

Suberiphenol

Suberiphenol

C27H38O3 (410.2821)


   

Flabellinone

Flabellinone

C27H38O3 (410.2821)


   

Topsentisterol E1

Topsentisterol E1

C28H42O2 (410.3185)


   
   

Cacospongin D

Cacospongin D

C27H38O3 (410.2821)


   

Nigrolineaquinone A

Nigrolineaquinone A

C27H38O3 (410.2821)


   

Asbestinin-25

Asbestinin-25

C23H38O6 (410.2668)


   

Chabrolobenzoquinone E

Chabrolobenzoquinone E

C27H38O3 (410.2821)


   

Amorfrutin B

3-Hydroxy-5-methoxy-4-geranylbibenzyl-2-carboxylic acid

C26H34O4 (410.2457)


   

Chabrolobenzoquinone G

(+)-Chabrolobenzoquinone G

C27H38O3 (410.2821)


   

Scopadulcic acid C

Scopadulcic acid C

C26H34O4 (410.2457)


   

(+)-Subersic acid

4-hydroxy-3-{(2E)-3-methyl-5-[(4aS,8aS)-2,5,5,8a-tetramethyl-3,4,4a,5,6,7,8,8a-octahydronaphthalen-1-yl]pent-2-en-1-yl}benzoic acid

C27H38O3 (410.2821)


A meroterpenoid that is 4,4,7,8a-tetramethyl-1,2,3,4,4a,5,6,8a-octahydronaphthalene substituted by a (3E)-5-(5-carboxy-2-hydroxyphenyl)-3-methylpent-3-en-1-yl moiety at position 8. It is isolated from the marine sponge Acanthodendrilla and exhibits inhibitory activity against the enzyme mitogen-activated protein kinase-activated protein kinase 2 (EC 2.7.11.1).

   

Dehydrorobustol B

Dehydrorobustol B

C26H34O4 (410.2457)


   

Boldenone Cypionate

Boldenone Cypionate

C27H38O3 (410.2821)


   

7-deacetylproceranone

7-deacetylproceranone

C26H34O4 (410.2457)


   

9(11)-dehydroergosterol peroxide

9(11)-dehydroergosterol peroxide

C28H42O2 (410.3185)


   

Nonactic-trihomononactic cyclic lactone

Nonactic-trihomononactic cyclic lactone

C23H38O6 (410.2668)


   

Australifunginol

Australifunginol

C23H38O6 (410.2668)


   

parvifoliol E

parvifoliol E

C28H42O2 (410.3185)


   

SCHEMBL6834503

SCHEMBL6834503

C27H38O3 (410.2821)


   

16-hydroxyprotylonolide

16-hydroxyprotylonolide

C23H38O6 (410.2668)


   

(+)-myelochroic acid

(+)-myelochroic acid

C23H38O6 (410.2668)


   

methyl-13S,15-dihydroxy-14R-acetoxy-1(10)-ent-halimen-18-oate

methyl-13S,15-dihydroxy-14R-acetoxy-1(10)-ent-halimen-18-oate

C23H38O6 (410.2668)


   

Trichilenone

Trichilenone

C26H34O4 (410.2457)


   

(2E,6E,10E)-2-(9-hydroxygeranylgeranyl)-6-methyl-1,4-benzoquinone|9-hydroxysargaquinone|Hydroxysargaquinone

(2E,6E,10E)-2-(9-hydroxygeranylgeranyl)-6-methyl-1,4-benzoquinone|9-hydroxysargaquinone|Hydroxysargaquinone

C27H38O3 (410.2821)


   

Tridentoquinone

Tridentoquinone

C26H34O4 (410.2457)


   
   

(Z)-p-coumaryl linolenate

(Z)-p-coumaryl linolenate

C27H38O3 (410.2821)


   

viridifloryl-alpha-4-O-acetyl-rhamnopyranoside

viridifloryl-alpha-4-O-acetyl-rhamnopyranoside

C23H38O6 (410.2668)


   
   

(2R)-9-oxo-delta-tocotrienol

(2R)-9-oxo-delta-tocotrienol

C27H38O3 (410.2821)


   

3-[5-(2,5,5,8a-tetramethyl-3,4,4a,6,7,8-hexahydronaphthalen-1-yl)-3-methylpent-2-enyl]-4-hydroxybenzoic acid

3-[5-(2,5,5,8a-tetramethyl-3,4,4a,6,7,8-hexahydronaphthalen-1-yl)-3-methylpent-2-enyl]-4-hydroxybenzoic acid

C27H38O3 (410.2821)


   
   

(6beta,22E)-6-Hydroxy-4,7,22-ergostatrien-3-one

(6beta,22E)-6-Hydroxy-4,7,22-ergostatrien-3-one

C28H42O2 (410.3185)


   

23-hydroxyprotylonolide

23-hydroxyprotylonolide

C23H38O6 (410.2668)


   

12beta-O-Acetyltomeutogenin

12beta-O-Acetyltomeutogenin

C23H38O6 (410.2668)


   

3-ketotaondiol

3-ketotaondiol

C27H38O3 (410.2821)


   

Lolanoquinon|Solanoquinone

Lolanoquinon|Solanoquinone

C28H42O2 (410.3185)


   

Sargadiol-II

Sargadiol-II

C27H38O3 (410.2821)


   

1beta,1beta:21,23-diepoxy-7alpha-hydroxy-24,25,26,27-tetranor-apotirucalla-14,20,22-trien-3-one

1beta,1beta:21,23-diepoxy-7alpha-hydroxy-24,25,26,27-tetranor-apotirucalla-14,20,22-trien-3-one

C26H34O4 (410.2457)


   

methyl-2alpha-acetoxy-3alpha,9beta-dihydroxy-9-epi-labd-13(E)-en-15-oate

methyl-2alpha-acetoxy-3alpha,9beta-dihydroxy-9-epi-labd-13(E)-en-15-oate

C23H38O6 (410.2668)


   

Abscisterol C

Abscisterol C

C27H38O3 (410.2821)


   

6alpha-({4-acetoxy}-7Z-coumaryloxy)eudesm-4(14)-ene

6alpha-({4-acetoxy}-7Z-coumaryloxy)eudesm-4(14)-ene

C26H34O4 (410.2457)


   

minabeolide-4

minabeolide-4

C27H38O3 (410.2821)


   

24-exomethylenecalicoferol E|24-exomethylenwcalicoferol E|24-methylenecalicoferol E

24-exomethylenecalicoferol E|24-exomethylenwcalicoferol E|24-methylenecalicoferol E

C28H42O2 (410.3185)


   

calicoferol D

(22E)-(8S)-3-hydroxy-22-methyl-9,10-seco-1,3,5(10),22-cholestatetraen-9-one

C28H42O2 (410.3185)


   

paraminabic acid A

paraminabic acid A

C27H38O3 (410.2821)


   

4,7,10,13,16,19,22-octacosaheptaenoic acid

4,7,10,13,16,19,22-octacosaheptaenoic acid

C28H42O2 (410.3185)


   

paraminabic acid B

paraminabic acid B

C27H38O3 (410.2821)


   

(rel-3S,5S,8R,9R,10S,13S,15S,16R)-3-acetoxy-9,13; 15,16-diepoxy-15,16-dimethoxylabdane|vitextrifolin A

(rel-3S,5S,8R,9R,10S,13S,15S,16R)-3-acetoxy-9,13; 15,16-diepoxy-15,16-dimethoxylabdane|vitextrifolin A

C23H38O6 (410.2668)


   

(25R)-19-norspirosta-1,3,5(10)-triene-4-methyl-2-ol

(25R)-19-norspirosta-1,3,5(10)-triene-4-methyl-2-ol

C27H38O3 (410.2821)


   

19-hydroxyprotylonolide

19-hydroxyprotylonolide

C23H38O6 (410.2668)


   

paniculatol

paniculatol

C26H34O4 (410.2457)


   

(2E,2E)-4-hydroxy-3-(3,7-dimethylocta-2,6-dienyl)-5-(3,7-dimethylocta-2,6-dienyl)benzoic acid|3,5-digeranyl-4-hydroxybenzoic acid|myrsinoic acid E

(2E,2E)-4-hydroxy-3-(3,7-dimethylocta-2,6-dienyl)-5-(3,7-dimethylocta-2,6-dienyl)benzoic acid|3,5-digeranyl-4-hydroxybenzoic acid|myrsinoic acid E

C27H38O3 (410.2821)


   

1-(2,4,6-trihydroxyphenyl)-5,8,11,14,17-eicosapentaen-1-one

1-(2,4,6-trihydroxyphenyl)-5,8,11,14,17-eicosapentaen-1-one

C26H34O4 (410.2457)


   

Mycaperoxide B

Mycaperoxide B

C24H42O5 (410.3032)


   

Gerronemin D

Gerronemin D

C27H38O3 (410.2821)


   

methyl (22E)-3-oxo-24-norcholesta-1,4,22-trien-26-one

methyl (22E)-3-oxo-24-norcholesta-1,4,22-trien-26-one

C27H38O3 (410.2821)


   

cyathisterol

cyathisterol

C28H42O2 (410.3185)


   

(20S)-20-hydroxyergosta-1,4,24(28)-trien-3-one|methyl (20S)-20-hydroxyergosta-1,4,24(28)-trien-3-one

(20S)-20-hydroxyergosta-1,4,24(28)-trien-3-one|methyl (20S)-20-hydroxyergosta-1,4,24(28)-trien-3-one

C28H42O2 (410.3185)


   

(3S,5R,6S,9Z)-Sinensiaxanthin

(3S,5R,6S,9Z)-Sinensiaxanthin

C27H38O3 (410.2821)


   

Incaspitolide A

Incaspitolide A

C23H38O6 (410.2668)


   
   

DTXSID80840527

DTXSID80840527

C27H38O3 (410.2821)


   

(24R)-24-methylcholesta-4,22E-dien-3,6-dione

(24R)-24-methylcholesta-4,22E-dien-3,6-dione

C28H42O2 (410.3185)


   

(22E,24R)-ergosta-7,22-dien-3,6-dione|(22E,24R)-ergosta-7,22-diene-3,6-dione|cyathisterone

(22E,24R)-ergosta-7,22-dien-3,6-dione|(22E,24R)-ergosta-7,22-diene-3,6-dione|cyathisterone

C28H42O2 (410.3185)


   

Sargadiol-I

Sargadiol-I

C27H38O3 (410.2821)


   

(2E,6E,10E)-4-hydroxy-3-(3,7,11,15-tetramethyl-hexadeca-2,6,10,14-tetraenyl)-benzoic acid|(2E,6E,10E)-4-hydroxy-3-(3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraenyl)benzoic acid|3-geranylgeranyl-4-hydroxybenzoic acid|4-Hydroxy-3-(3,7,11,15-tetramethyl-2,6,10,14-hexadecatetraenyl)benzoic acid|4-hydroxy-3-(E,E,E-3,7,11,15-tetramethyl-hexadeca-2,6,10,14-tetraenyl)benzoic acid|4-Hydroxy-3-tetraprenylbenzoesaeure|4-hydroxy-3-tetraprenylbenzoicacid

(2E,6E,10E)-4-hydroxy-3-(3,7,11,15-tetramethyl-hexadeca-2,6,10,14-tetraenyl)-benzoic acid|(2E,6E,10E)-4-hydroxy-3-(3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraenyl)benzoic acid|3-geranylgeranyl-4-hydroxybenzoic acid|4-Hydroxy-3-(3,7,11,15-tetramethyl-2,6,10,14-hexadecatetraenyl)benzoic acid|4-hydroxy-3-(E,E,E-3,7,11,15-tetramethyl-hexadeca-2,6,10,14-tetraenyl)benzoic acid|4-Hydroxy-3-tetraprenylbenzoesaeure|4-hydroxy-3-tetraprenylbenzoicacid

C27H38O3 (410.2821)


   

1-(1-methylethyl)-4-methyl-3-cyclohexenyl 3,5-bis(3-methyl-2-butenyl)-4-hydroxybenzoate

1-(1-methylethyl)-4-methyl-3-cyclohexenyl 3,5-bis(3-methyl-2-butenyl)-4-hydroxybenzoate

C27H38O3 (410.2821)


   

mycaperoxide A

mycaperoxide A

C24H42O5 (410.3032)


   
   

tilorone

tilorone

C25H34N2O3 (410.2569)


J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals D007155 - Immunologic Factors > D007369 - Interferon Inducers D000890 - Anti-Infective Agents > D000998 - Antiviral Agents C254 - Anti-Infective Agent > C281 - Antiviral Agent D000893 - Anti-Inflammatory Agents D000970 - Antineoplastic Agents Tilorone is an orally active antiviral agent and interferon inducer that also has potential antineoplastic, immunomodulatory, and metabolic modulating effects. Tilorone induces an abnormally delayed interferon response and primarily stimulates interferon production in lymphoid tissue. Thus, Tilorone exerts antiviral effects and can be used as a chemotherapeutic agent. Tilorone has the potential to inhibit type 2 diabetes by increasing glucose uptake in vivo and in skeletal muscle cells by enhancing Akt2/AS160 signaling and glucose transporter levels[1][2][3][4][5].

   
   
   
   

histidylvalylarginine

histidylvalylarginine

C17H30N8O4 (410.239)


   
   
   
   
   
   

valylhistidylarginine

valylhistidylarginine

C17H30N8O4 (410.239)


   
   

gamma-Tocotrienol

2,7,8-TRIMETHYL-2-[(3E,7E,11E,15E,19E,23E,27E)-4,8,12,16,20,24,28,32-O CTAMETHYL-3,7,11,15,19,23,27,31-TRITRIACONTAOCTAENYL]-6-CHROMANOL

C28H42O2 (410.3185)


gamma-Tocotrienol, also known as 7,8-dimethyltocotrienol, belongs to the class of organic compounds known as tocotrienols. These are vitamin E derivatives containing an unsaturated trimethyltrideca-3,7,11-trien-1-yl chain attached to the C6 atom of a benzopyran ring system. They differ from tocopherols that contain a saturated trimethyltridecyl chain. Thus, gamma-tocotrienol is considered to be a quinone lipid molecule. gamma-Tocotrienol is a very hydrophobic molecule, practically insoluble (in water), and relatively neutral. gamma-Tocotrienol targets cancer cells by inhibiting Id1, a key cancer-promoting protein. gamma-Tocotrienol was shown to trigger cell apoptosis and well as anti-proliferation of cancer cells. This mechanism was also observed in separate prostate cancer and melanoma cell line studies. Gamma-tocotrienol is a tocotrienol that is chroman-6-ol substituted by methyl groups at positions 2, 7 and 8 and a farnesyl chain at position 2. A vitamin E family member that has potent anti-cancer properties against a wide-range of cancers. It has a role as an antioxidant, an antineoplastic agent, a plant metabolite, a radiation protective agent, an apoptosis inducer and a hepatoprotective agent. It is a tocotrienol and a vitamin E. gamma-Tocotrienol is a natural product found in Amaranthus cruentus, Triadica sebifera, and other organisms with data available. A tocotrienol that is chroman-6-ol substituted by methyl groups at positions 2, 7 and 8 and a farnesyl chain at position 2. A vitamin E family member that has potent anti-cancer properties against a wide-range of cancers. Constituent of palm oil. Nutriceutical with anticancer props. and a positive influence on the blood lipid profile. gamma-Tocotrienol is found in many foods, some of which are rye, corn, rosemary, and common grape. γ-Tocotrienol is an active form of vitamin E. γ-tocotrienol reverses the multidrug resistance (MDR) of breast cancer cells through the signaling pathway of NF-κB and P-gp. γ-Tocotrienol is also a novel radioprotector agent, can mitigate bone marrow radiation damage during targeted radionuclide treatment[1][2][3]. γ-Tocotrienol is an active form of vitamin E. γ-tocotrienol reverses the multidrug resistance (MDR) of breast cancer cells through the signaling pathway of NF-κB and P-gp. γ-Tocotrienol is also a novel radioprotector agent, can mitigate bone marrow radiation damage during targeted radionuclide treatment[1][2][3].

   

γ-Tocotrienol

gamma-Tocotrienol

C28H42O2 (410.3185)


γ-Tocotrienol is an active form of vitamin E. γ-tocotrienol reverses the multidrug resistance (MDR) of breast cancer cells through the signaling pathway of NF-κB and P-gp. γ-Tocotrienol is also a novel radioprotector agent, can mitigate bone marrow radiation damage during targeted radionuclide treatment[1][2][3]. γ-Tocotrienol is an active form of vitamin E. γ-tocotrienol reverses the multidrug resistance (MDR) of breast cancer cells through the signaling pathway of NF-κB and P-gp. γ-Tocotrienol is also a novel radioprotector agent, can mitigate bone marrow radiation damage during targeted radionuclide treatment[1][2][3].

   

NCGC00385436-01!

NCGC00385436-01!

C26H34O4 (410.2457)


   

[2-hydroxy-3-phosphonooxypropyl] hexadecanoate

[2-hydroxy-3-phosphonooxypropyl] hexadecanoate

C19H39O7P (410.2433)


   

4-hydroxy-3-tetratrenylbenzoic acid

4-hydroxy-3-tetratrenylbenzoic acid

C27H38O3 (410.2821)


   
   

Pro Pro Val Val

(2S)-3-methyl-2-[(2S)-3-methyl-2-{[(2S)-1-{[(2S)-pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}butanamido]butanoic acid

C20H34N4O5 (410.2529)


   

Pro Val Pro Val

(2S)-3-methyl-2-{[(2S)-1-[(2S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]butanoyl]pyrrolidin-2-yl]formamido}butanoic acid

C20H34N4O5 (410.2529)


   

Pro Val Val Pro

(2S)-1-[(2S)-3-methyl-2-[(2S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]butanoyl]pyrrolidine-2-carboxylic acid

C20H34N4O5 (410.2529)


   

2,2,6,6-Tetra-tert-butyl-4,4-biphenol

3,3,5,5-Tetra-tert-butyl-4,4-dihydroxybiphenyl

C28H42O2 (410.3185)


   
   

Val Pro Pro Val

(2S)-2-{[(2S)-1-{[(2S)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}-3-methylbutanoic acid

C20H34N4O5 (410.2529)


   

Val Pro Val Pro

(2S)-1-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanoyl]pyrrolidine-2-carboxylic acid

C20H34N4O5 (410.2529)


   

Val Val Pro Pro

(2S)-1-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-methylbutanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidine-2-carboxylic acid

C20H34N4O5 (410.2529)


   

PGF2α-11-acetate methyl ester

methyl 9S,15S-dihydroxy-11R-acetoxy-5Z,13E-prostadienoate

C23H38O6 (410.2668)


   

PA(16:0/0:0)

Hexadecanoic acid, 2-hydroxy-3-(phosphonooxy)propyl ester, (R)-

C19H39O7P (410.2433)


   

(5Z,7E,22E)-(1S,3R)-1,3-dihydroxy-26,27-cyclo-9,10-seco-5,7,10(19),22-cholestatetraen-24-one

(22E)-1α-hydroxy-24-oxo-26,27-cyclo-22,23-didehydrovitamin D3 / (22E)-1α-hydroxy-24-oxo-26,27-cyclo-22,23-didehydrocholecalciferol

C27H38O3 (410.2821)


   

(5Z,7E)-(1S,3R)-24,25-epoxy-9,10-seco-5,7,10(19)-cholestatrien-22-yne-1,3-diol

24,25-epoxy-1α-hydroxy-22,22,23,23-tetradehydrovitamin D3 / 24,25-epoxy-1α-hydroxy-22,22,23,23-tetradehydrocholecalciferol

C27H38O3 (410.2821)


   

(5Z,7E)-(1S,3R)-25,26-epoxy-9,10-seco-5,7,10(19)-cholestatrien-23-yne-1,3-diol

25,26-epoxy-1α-hydroxy-23,23,24,24-tetradehydrovitamin D3 / 25,26-epoxy-1α-hydroxy-23,23,24,24-tetradehydrocholecalciferol

C27H38O3 (410.2821)


   

(5Z,7E)-(1S,3R,20S)-25,26-epoxy-9,10-seco-5,7,10(19)-cholestatrien-23-yne-1,3-diol

25,26-epoxy-1α-hydroxy-23,23,24,24-tetradehydro-20-epivitamin D3 / 25,26-epoxy-1α-hydroxy-23,23,24,24-tetradehydro-20-epicholecalciferol

C27H38O3 (410.2821)


   

(5Z,7E)-(1S,3R)-9,10-seco-5,7,10(19),16-cholestatetraen-23-yne-1,3,25-triol

1α,25-dihydroxy-16,17,23,23,24,24-hexadehydrovitamin D3 / 1α,25-dihydroxy-16,17,23,23,24,24-hexadehydrocholecalciferol

C27H38O3 (410.2821)


   

LysoPA(16:0)

2-Hexadecanoyl-phosphatidic acid

C19H39O7P (410.2433)


   

isopropyl ester

9,11,15S-trihydroxy-15-methyl-prosta-5Z,13E-dien-1-oic acid, isopropyl ester

C24H42O5 (410.3032)


   

N-oleoyl glutamine

N-(9Z-octadecenoyl)-glutamine

C23H42N2O4 (410.3144)


   

3beta-Hydroxy-(22E,24R)-ergosta-5,8,22-trien-7-one

14-[(3E)-5,6-dimethylhept-3-en-2-yl]-5-hydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-1(10),7-dien-9-one

C28H42O2 (410.3185)


   

(6alpha,22E)-6-Hydroxy-4,7,22-ergostatrien-3-one

14-[(3E)-5,6-dimethylhept-3-en-2-yl]-8-hydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-6,9-dien-5-one

C28H42O2 (410.3185)


   

5,8-Epoxy-5,8-dihydro-10'-apo-b,y-carotene-3,10'-diol

2-[(2Z,4E,6E,8E,10E,12E)-14-hydroxy-6,11-dimethyltetradeca-2,4,6,8,10,12-hexaen-2-yl]-4,4,7a-trimethyl-2,4,5,6,7,7a-hexahydro-1-benzofuran-6-ol

C27H38O3 (410.2821)


   

5,6-Epoxy-5,6-dihydro-10'-apo-b,y-carotene-3,10'-diol

6-[(1E,3Z,5E,7E,9E,11Z,13Z)-15-hydroxy-3,7,12-trimethylpentadeca-1,3,5,7,9,11,13-heptaen-1-yl]-1,5,5-trimethyl-7-oxabicyclo[4.1.0]heptan-3-ol

C27H38O3 (410.2821)


   

28:7(n-6)

4Z,7Z,10Z,13Z,16Z,19Z,22Z-octacosaheptaenoic acid

C28H42O2 (410.3185)


   

FA 28:7

4Z,7Z,10Z,13Z,16Z,19Z,22Z-octacosaheptaenoic acid

C28H42O2 (410.3185)


   

FA 23:4;O4

methyl 9S,15S-dihydroxy-11R-acetoxy-5Z,13E-prostadienoate

C23H38O6 (410.2668)


   

mLPA(O-16:0)

1-O-hexadecyl-sn-glycero-3-phosphoric acid methyl ester

C20H43O6P (410.2797)


   

LPA 16:0

Hexadecanoic acid, 2-hydroxy-3-(phosphonooxy)propyl ester, (R)-

C19H39O7P (410.2433)


   

ST 28:4;O2

12alpha-hydroxyergosta-7,22,24(28)-triene-3-one

C28H42O2 (410.3185)


   

ST 27:5;O3

28-nor-3-oxo-witha-1,4-dienolide

C27H38O3 (410.2821)


   

(22E)-1alpha-hydroxy-24-oxo-26,27-cyclo-22,23-didehydrovitamin D3

(5Z,7E,22E)-(1S,3R)-1,3-dihydroxy-26,27-cyclo-9,10-seco-5,7,10(19),22-cholestatetraen-24-one

C27H38O3 (410.2821)


   

24,25-epoxy-1alpha-hydroxy-22,22,23,23-tetradehydrovitamin D3

(5Z,7E)-(1S,3R)-24,25-epoxy-9,10-seco-5,7,10(19)-cholestatrien-22-yne-1,3-diol

C27H38O3 (410.2821)


   

25,26-epoxy-1alpha-hydroxy-23,23,24,24-tetradehydrovitamin D3

(5Z,7E)-(1S,3R)-25,26-epoxy-9,10-seco-5,7,10(19)-cholestatrien-23-yne-1,3-diol

C27H38O3 (410.2821)


   

25,26-epoxy-1alpha-hydroxy-23,23,24,24-tetradehydro-20-epivitamin D3

(5Z,7E)-(1S,3R,20S)-25,26-epoxy-9,10-seco-5,7,10(19)-cholestatrien-23-yne-1,3-diol

C27H38O3 (410.2821)


   

Chinensen B

2,5-dihydroxy-3-geranylgeranyl benzaldehyde

C27H38O3 (410.2821)


   
   
   

2-eicosa-5Z,8Z,11Z,14Z,17Z-pentaenoylphloroglucinol

1-(2,4,6-Trihydroxyphenyl)-5Z,8Z,11Z,14Z,17Z-eicosapenten-1-one

C26H34O4 (410.2457)


   

trans,trans-3,4,5-trifluorophenyl 4-pentylbicyclohexyl-4-carboxylate

trans,trans-3,4,5-trifluorophenyl 4-pentylbicyclohexyl-4-carboxylate

C24H33F3O2 (410.2433)


   

boc-d-cyclopropylalanine-dcha

boc-d-cyclopropylalanine-dcha

C23H42N2O4 (410.3144)


   

3,3,5,5-Tetra-tert-butyl-2,2-biphenyldiol

3,3,5,5-Tetra-tert-butyl-2,2-biphenyldiol

C28H42O2 (410.3185)


   

Pyridinium,1-[[(1-oxooctadecyl)amino]methyl]-, chloride (1:1)

Pyridinium,1-[[(1-oxooctadecyl)amino]methyl]-, chloride (1:1)

C24H43ClN2O (410.3064)


   

Hydroxy-PEG6-Boc

Hydroxy-PEG6-Boc

C19H38O9 (410.2516)


   

boc-4,5-dehydro-leu-oh dcha

boc-4,5-dehydro-leu-oh dcha

C23H42N2O4 (410.3144)


   

1,6-Bis(Triethoxysilyl)Hexane

1,6-Bis(Triethoxysilyl)Hexane

C18H42O6Si2 (410.252)


   

phenyl acetaldehyde digeranyl acetal

phenyl acetaldehyde digeranyl acetal

C28H42O2 (410.3185)


   

ornoprostil

ornoprostil

C23H38O6 (410.2668)


C78568 - Prostaglandin Analogue

   

methyl trimethyl-3-[(1-oxododecyl)amino]propylammonium sulphate

methyl trimethyl-3-[(1-oxododecyl)amino]propylammonium sulphate

C19H42N2O5S (410.2814)


   

1-Naphthyl stearate

1-Naphthyl stearate

C28H42O2 (410.3185)


   

Trenbolone cyclohexylmethylcarbonate

Trenbolone cyclohexylmethylcarbonate

C26H34O4 (410.2457)


   

1-(2-ethoxyethyl)-2-[[4-(4-pyrazol-1-ylbutyl)piperazin-1-yl]methyl]benzimidazole

1-(2-ethoxyethyl)-2-[[4-(4-pyrazol-1-ylbutyl)piperazin-1-yl]methyl]benzimidazole

C23H34N6O (410.2794)


   

Octadecanoic acid,2-naphthalenyl ester

Octadecanoic acid,2-naphthalenyl ester

C28H42O2 (410.3185)


   
   

1,1-Biphenyl, 4-[(trans,trans)-4-butyl[1,1-bicyclohexyl]-4-yl]-3,4-difluoro-

1,1-Biphenyl, 4-[(trans,trans)-4-butyl[1,1-bicyclohexyl]-4-yl]-3,4-difluoro-

C28H36F2 (410.2785)


   

1-Ethoxy-2,3-difluoro-4-[[4-(trans-4-pentylcyclohexyl)phenyl]ethynyl]benzene

1-Ethoxy-2,3-difluoro-4-[[4-(trans-4-pentylcyclohexyl)phenyl]ethynyl]benzene

C27H32F2O (410.2421)


   

trans-4-Pentylcyclohexanecarboxylic acid 2,3-dicyano-4-(pentyloxy)phenyl ester

trans-4-Pentylcyclohexanecarboxylic acid 2,3-dicyano-4-(pentyloxy)phenyl ester

C25H34N2O3 (410.2569)


   

Boc-L-Cyclopropylalanine-DCHA

Boc-L-Cyclopropylalanine-DCHA

C23H42N2O4 (410.3144)


   

(Z)-4-[3-(2-CHLORO-9H-THIOXANTHEN-9-YLIDENE)PROPYL]PIPERAZINE-1-ETHANOLDIHYDROCHLORIDE

(Z)-4-[3-(2-CHLORO-9H-THIOXANTHEN-9-YLIDENE)PROPYL]PIPERAZINE-1-ETHANOLDIHYDROCHLORIDE

C23H38O6 (410.2668)


   

(2R)-2-hydroxy-3-(phosphonooxy)propyl hexadecanoate

(2R)-2-hydroxy-3-(phosphonooxy)propyl hexadecanoate

C19H39O7P (410.2433)


   

Methestrol dipropionate

Methestrol dipropionate

C26H34O4 (410.2457)


   

Norethisterone enanthate

Norethisterone enanthate

C27H38O3 (410.2821)


D012102 - Reproductive Control Agents > D003270 - Contraceptive Agents

   

GS-9620

Vesatolimod

C22H30N6O2 (410.243)


D000890 - Anti-Infective Agents > D000998 - Antiviral Agents C308 - Immunotherapeutic Agent > C2139 - Immunostimulant C254 - Anti-Infective Agent > C281 - Antiviral Agent

   

CHEBI:33277

2H-1-Benzopyran-6-ol, 3,4-dihydro-2,7,8-trimethyl-2-[(3E,7E)-4,8,12-trimethyl-3,7,11-tridecatrienyl]-, (2R)- (9CI)

C28H42O2 (410.3185)


γ-Tocotrienol is an active form of vitamin E. γ-tocotrienol reverses the multidrug resistance (MDR) of breast cancer cells through the signaling pathway of NF-κB and P-gp. γ-Tocotrienol is also a novel radioprotector agent, can mitigate bone marrow radiation damage during targeted radionuclide treatment[1][2][3]. γ-Tocotrienol is an active form of vitamin E. γ-tocotrienol reverses the multidrug resistance (MDR) of breast cancer cells through the signaling pathway of NF-κB and P-gp. γ-Tocotrienol is also a novel radioprotector agent, can mitigate bone marrow radiation damage during targeted radionuclide treatment[1][2][3].

   

(2R)-2,7,8-Trimethyl-2-(4,8,12-trimethyltrideca-3,7,11-trienyl)-3,4-dihydrochromen-6-ol

2,7,8-trimethyl-2-(4,8,12-trimethyltrideca-3,7,11-trien-1-yl)-3,4-dihydro-2H-1-benzopyran-6-ol

C28H42O2 (410.3185)


   

[(2R)-2-(hexadecanoyloxy)-3-hydroxypropoxy]phosphonic acid

[(2R)-2-(hexadecanoyloxy)-3-hydroxypropoxy]phosphonic acid

C19H39O7P (410.2433)


   

Norethisterone enanthate

14-ethynyl-15-methyl-5-oxotetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-14-yl heptanoate

C27H38O3 (410.2821)


   

3,4-Dihydro-2,7,8-trimethyl-2-[(3E,7E)-4,8,12-trimethyl-3,7,11-tridecatrienyl]-2H-1-benzopyran-6-ol

3,4-Dihydro-2,7,8-trimethyl-2-[(3E,7E)-4,8,12-trimethyl-3,7,11-tridecatrienyl]-2H-1-benzopyran-6-ol

C28H42O2 (410.3185)


   

dianhydro-D-mannitol monooleate

dianhydro-D-mannitol monooleate

C24H42O5 (410.3032)


   

5-amino-2-[[(E)-octadec-9-enoyl]amino]-5-oxopentanoic acid

5-amino-2-[[(E)-octadec-9-enoyl]amino]-5-oxopentanoic acid

C23H42N2O4 (410.3144)


   

MG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/0:0)

MG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/0:0)

C23H38O6 (410.2668)


   

MG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/0:0)

MG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/0:0)

C23H38O6 (410.2668)


   

MG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/0:0)

MG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/0:0)

C23H38O6 (410.2668)


   

MG(0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0)

MG(0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0)

C23H38O6 (410.2668)


   

MG(0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0)

MG(0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0)

C23H38O6 (410.2668)


   

MG(0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0)

MG(0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0)

C23H38O6 (410.2668)


   

DG(2:0/18:2(10E,12Z)+=O(9)/0:0)

DG(2:0/18:2(10E,12Z)+=O(9)/0:0)

C23H38O6 (410.2668)


   

DG(18:2(10E,12Z)+=O(9)/2:0/0:0)

DG(18:2(10E,12Z)+=O(9)/2:0/0:0)

C23H38O6 (410.2668)


   

DG(2:0/0:0/18:2(10E,12Z)+=O(9))

DG(2:0/0:0/18:2(10E,12Z)+=O(9))

C23H38O6 (410.2668)


   

DG(18:2(10E,12Z)+=O(9)/0:0/2:0)

DG(18:2(10E,12Z)+=O(9)/0:0/2:0)

C23H38O6 (410.2668)


   

DG(2:0/18:2(9Z,11E)+=O(13)/0:0)

DG(2:0/18:2(9Z,11E)+=O(13)/0:0)

C23H38O6 (410.2668)


   

DG(18:2(9Z,11E)+=O(13)/2:0/0:0)

DG(18:2(9Z,11E)+=O(13)/2:0/0:0)

C23H38O6 (410.2668)


   

DG(2:0/0:0/18:2(9Z,11E)+=O(13))

DG(2:0/0:0/18:2(9Z,11E)+=O(13))

C23H38O6 (410.2668)


   

DG(18:2(9Z,11E)+=O(13)/0:0/2:0)

DG(18:2(9Z,11E)+=O(13)/0:0/2:0)

C23H38O6 (410.2668)


   

[(2S)-1-acetyloxy-3-hydroxypropan-2-yl] (10E,12E,15E)-9-hydroxyoctadeca-10,12,15-trienoate

[(2S)-1-acetyloxy-3-hydroxypropan-2-yl] (10E,12E,15E)-9-hydroxyoctadeca-10,12,15-trienoate

C23H38O6 (410.2668)


   

[(2S)-2-acetyloxy-3-hydroxypropyl] (10E,12E,15E)-9-hydroxyoctadeca-10,12,15-trienoate

[(2S)-2-acetyloxy-3-hydroxypropyl] (10E,12E,15E)-9-hydroxyoctadeca-10,12,15-trienoate

C23H38O6 (410.2668)


   

[(2R)-3-acetyloxy-2-hydroxypropyl] (10E,12E,15E)-9-hydroxyoctadeca-10,12,15-trienoate

[(2R)-3-acetyloxy-2-hydroxypropyl] (10E,12E,15E)-9-hydroxyoctadeca-10,12,15-trienoate

C23H38O6 (410.2668)


   

[(2S)-3-acetyloxy-2-hydroxypropyl] (10E,12E,15E)-9-hydroxyoctadeca-10,12,15-trienoate

[(2S)-3-acetyloxy-2-hydroxypropyl] (10E,12E,15E)-9-hydroxyoctadeca-10,12,15-trienoate

C23H38O6 (410.2668)


   

[(2S)-1-acetyloxy-3-hydroxypropan-2-yl] (9E,11E,15E)-13-hydroxyoctadeca-9,11,15-trienoate

[(2S)-1-acetyloxy-3-hydroxypropan-2-yl] (9E,11E,15E)-13-hydroxyoctadeca-9,11,15-trienoate

C23H38O6 (410.2668)


   

[(2S)-2-acetyloxy-3-hydroxypropyl] (9E,11E,15E)-13-hydroxyoctadeca-9,11,15-trienoate

[(2S)-2-acetyloxy-3-hydroxypropyl] (9E,11E,15E)-13-hydroxyoctadeca-9,11,15-trienoate

C23H38O6 (410.2668)


   

[(2R)-3-acetyloxy-2-hydroxypropyl] (9E,11E,15E)-13-hydroxyoctadeca-9,11,15-trienoate

[(2R)-3-acetyloxy-2-hydroxypropyl] (9E,11E,15E)-13-hydroxyoctadeca-9,11,15-trienoate

C23H38O6 (410.2668)


   

[(2S)-3-acetyloxy-2-hydroxypropyl] (9E,11E,15E)-13-hydroxyoctadeca-9,11,15-trienoate

[(2S)-3-acetyloxy-2-hydroxypropyl] (9E,11E,15E)-13-hydroxyoctadeca-9,11,15-trienoate

C23H38O6 (410.2668)


   

[3-carboxy-2-[(3E,5E,11E)-14-carboxytetradeca-3,5,11-trienoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(3E,5E,11E)-14-carboxytetradeca-3,5,11-trienoyl]oxypropyl]-trimethylazanium

C22H36NO6+ (410.2542)


   

[3-carboxy-2-[(9E,11E,13E)-14-carboxytetradeca-9,11,13-trienoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(9E,11E,13E)-14-carboxytetradeca-9,11,13-trienoyl]oxypropyl]-trimethylazanium

C22H36NO6+ (410.2542)


   

[3-carboxy-2-[(3E,6E,9E)-14-carboxytetradeca-3,6,9-trienoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(3E,6E,9E)-14-carboxytetradeca-3,6,9-trienoyl]oxypropyl]-trimethylazanium

C22H36NO6+ (410.2542)


   

[3-carboxy-2-[(7E,10E,13E)-14-carboxytetradeca-7,10,13-trienoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(7E,10E,13E)-14-carboxytetradeca-7,10,13-trienoyl]oxypropyl]-trimethylazanium

C22H36NO6+ (410.2542)


   

[3-carboxy-2-[(4E,6E,8E)-14-carboxytetradeca-4,6,8-trienoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(4E,6E,8E)-14-carboxytetradeca-4,6,8-trienoyl]oxypropyl]-trimethylazanium

C22H36NO6+ (410.2542)


   

[3-carboxy-2-[(5E,8E,11E)-14-carboxytetradeca-5,8,11-trienoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(5E,8E,11E)-14-carboxytetradeca-5,8,11-trienoyl]oxypropyl]-trimethylazanium

C22H36NO6+ (410.2542)


   

[3-carboxy-2-[(2E,6E,10E)-14-carboxytetradeca-2,6,10-trienoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(2E,6E,10E)-14-carboxytetradeca-2,6,10-trienoyl]oxypropyl]-trimethylazanium

C22H36NO6+ (410.2542)


   

[3-carboxy-2-[(5E,7E,9E)-14-carboxytetradeca-5,7,9-trienoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(5E,7E,9E)-14-carboxytetradeca-5,7,9-trienoyl]oxypropyl]-trimethylazanium

C22H36NO6+ (410.2542)


   

[3-carboxy-2-[(3E,5E,7E)-14-carboxytetradeca-3,5,7-trienoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(3E,5E,7E)-14-carboxytetradeca-3,5,7-trienoyl]oxypropyl]-trimethylazanium

C22H36NO6+ (410.2542)


   

[3-Carboxy-2-[5-(3,4-dimethyl-5-pentylfuran-2-yl)pentanoyloxy]propyl]-trimethylazanium

[3-Carboxy-2-[5-(3,4-dimethyl-5-pentylfuran-2-yl)pentanoyloxy]propyl]-trimethylazanium

C23H40NO5+ (410.2906)


   

[3-Carboxy-2-[6-(5-hexylfuran-2-yl)hexanoyloxy]propyl]-trimethylazanium

[3-Carboxy-2-[6-(5-hexylfuran-2-yl)hexanoyloxy]propyl]-trimethylazanium

C23H40NO5+ (410.2906)


   

[3-Carboxy-2-[7-(3,4-dimethyl-5-propylfuran-2-yl)heptanoyloxy]propyl]-trimethylazanium

[3-Carboxy-2-[7-(3,4-dimethyl-5-propylfuran-2-yl)heptanoyloxy]propyl]-trimethylazanium

C23H40NO5+ (410.2906)


   

[3-Carboxy-2-[7-(5-pentylfuran-2-yl)heptanoyloxy]propyl]-trimethylazanium

[3-Carboxy-2-[7-(5-pentylfuran-2-yl)heptanoyloxy]propyl]-trimethylazanium

C23H40NO5+ (410.2906)


   

[2-[8-(5-Butylfuran-2-yl)octanoyloxy]-3-carboxypropyl]-trimethylazanium

[2-[8-(5-Butylfuran-2-yl)octanoyloxy]-3-carboxypropyl]-trimethylazanium

C23H40NO5+ (410.2906)


   

(5Z)-5-[(2E)-2-[1-(6-hydroxy-6-methylhept-4-yn-2-yl)-7a-methyl-3a,5,6,7-tetrahydro-3H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol

(5Z)-5-[(2E)-2-[1-(6-hydroxy-6-methylhept-4-yn-2-yl)-7a-methyl-3a,5,6,7-tetrahydro-3H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol

C27H38O3 (410.2821)


   

Minabeolide 4

Minabeolide 4

C27H38O3 (410.2821)


A withanolide that is (22R,25S)-22,26-epoxycholesta-1,4-dien-26-one substituted by an oxo group at position 3. Isolated from Paraminabea acronocephala,it exhibits anti-inflammatory activity.

   

(22E,24R)-ergosta-7,22-diene-3,6-dione

(22E,24R)-ergosta-7,22-diene-3,6-dione

C28H42O2 (410.3185)


A 3-oxo Delta(7)-steroid that is (22E)-ergosta-7,22-diene substituted by oxo groups at positions 3 and 6. It has been isolated from Penicillium commune.

   

7-Hexyl-3-methyl-8-(4-phenyl-1-piperazinyl)purine-2,6-dione

7-Hexyl-3-methyl-8-(4-phenyl-1-piperazinyl)purine-2,6-dione

C22H30N6O2 (410.243)


   
   

N-arachidonoyltaurine(1-)

N-arachidonoyltaurine(1-)

C22H36NO4S- (410.2365)


A fatty acid-taurine conjugate obtained by deprotonation of the sulfonate group of N-arachidonoyltaurine; major species at pH 7.3.

   

N-[2-[4-(4-fluorophenyl)-1-piperazinyl]-2-(3-pyridinyl)ethyl]cyclohexanecarboxamide

N-[2-[4-(4-fluorophenyl)-1-piperazinyl]-2-(3-pyridinyl)ethyl]cyclohexanecarboxamide

C24H31FN4O (410.2482)


   

5-tert-butyl-N-[2-(cyclopentylamino)-2-oxoethyl]-N-(2,5-dimethylphenyl)-3-methyl-2-furancarboxamide

5-tert-butyl-N-[2-(cyclopentylamino)-2-oxoethyl]-N-(2,5-dimethylphenyl)-3-methyl-2-furancarboxamide

C25H34N2O3 (410.2569)


   

benzoic acid [3-hydroxy-10-(hydroxymethyl)-13-methyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl] ester

benzoic acid [3-hydroxy-10-(hydroxymethyl)-13-methyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl] ester

C26H34O4 (410.2457)


   

12-HPETE 2-glyceryl ester

12-HPETE 2-glyceryl ester

C23H38O6 (410.2668)


   

N-Benzyl-3-[(2S,5aS,8aR)-6-(1H-imidazol-2-ylmethyl)-1-methyl-5-oxodecahydropyrrolo[3,2-E][1,4]diazepin-2-yl]propanamide

N-Benzyl-3-[(2S,5aS,8aR)-6-(1H-imidazol-2-ylmethyl)-1-methyl-5-oxodecahydropyrrolo[3,2-E][1,4]diazepin-2-yl]propanamide

C22H30N6O2 (410.243)


   

1,3-dihydroxypropan-2-yl (5Z,8Z,11Z,13E,15S)-15-hydroperoxyicosa-5,8,11,13-tetraenoate

1,3-dihydroxypropan-2-yl (5Z,8Z,11Z,13E,15S)-15-hydroperoxyicosa-5,8,11,13-tetraenoate

C23H38O6 (410.2668)


   
   

[3-carboxy-2-[(11E,14E)-heptadeca-11,14-dienoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(11E,14E)-heptadeca-11,14-dienoyl]oxypropyl]-trimethylazanium

C24H44NO4+ (410.327)


   

(E)-3-(((quinolin-8-ylmethylene)amino)oxy)butyl undec-10-enoate

(E)-3-(((quinolin-8-ylmethylene)amino)oxy)butyl undec-10-enoate

C25H34N2O3 (410.2569)


   

CID 38362561

CID 38362561

C26H34O4 (410.2457)


   
   
   
   
   

Pro-Val-Val-Pro

Pro-Val-Val-Pro

C20H34N4O5 (410.2529)


   

Palmitoylglycerol-phosphate

Palmitoylglycerol-phosphate

C19H39O7P (410.2433)


   

3-[[(3R,5R,7S,8E,10E,12E)-3-amino-5-hydroxy-7-methoxyoctadeca-8,10,12-trienoyl]amino]propanoic acid

3-[[(3R,5R,7S,8E,10E,12E)-3-amino-5-hydroxy-7-methoxyoctadeca-8,10,12-trienoyl]amino]propanoic acid

C22H38N2O5 (410.2781)


   

3-(3,7,11,15-Tetramethyl-2,6,10,14-hexadecatetrenyl)-4-hydroxybenzoic acid

3-(3,7,11,15-Tetramethyl-2,6,10,14-hexadecatetrenyl)-4-hydroxybenzoic acid

C27H38O3 (410.2821)


   

[2-(Butanoylamino)-3-hydroxynonyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-(Butanoylamino)-3-hydroxynonyl] 2-(trimethylazaniumyl)ethyl phosphate

C18H39N2O6P (410.2546)


   

(2-Acetamido-3-hydroxyundecyl) 2-(trimethylazaniumyl)ethyl phosphate

(2-Acetamido-3-hydroxyundecyl) 2-(trimethylazaniumyl)ethyl phosphate

C18H39N2O6P (410.2546)


   

[3-Hydroxy-2-(propanoylamino)decyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-Hydroxy-2-(propanoylamino)decyl] 2-(trimethylazaniumyl)ethyl phosphate

C18H39N2O6P (410.2546)


   

(7Z,10Z,13Z,16Z,19Z,22Z,25Z)-octacosa-7,10,13,16,19,22,25-heptaenoic acid

(7Z,10Z,13Z,16Z,19Z,22Z,25Z)-octacosa-7,10,13,16,19,22,25-heptaenoic acid

C28H42O2 (410.3185)


   

[3-Hydroxy-2-(pentanoylamino)octyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-Hydroxy-2-(pentanoylamino)octyl] 2-(trimethylazaniumyl)ethyl phosphate

C18H39N2O6P (410.2546)


   

1,2-Dihexyl-1,2-dimethyl 1,2-diphenyldisilane

1,2-Dihexyl-1,2-dimethyl 1,2-diphenyldisilane

C26H42Si2 (410.2825)


   

(1-hydroxy-3-propanoyloxypropan-2-yl) (9Z,12Z)-octadeca-9,12-dienoate

(1-hydroxy-3-propanoyloxypropan-2-yl) (9Z,12Z)-octadeca-9,12-dienoate

C24H42O5 (410.3032)


   

(1-butanoyloxy-3-hydroxypropan-2-yl) (9Z,12Z)-heptadeca-9,12-dienoate

(1-butanoyloxy-3-hydroxypropan-2-yl) (9Z,12Z)-heptadeca-9,12-dienoate

C24H42O5 (410.3032)


   

(1-acetyloxy-3-hydroxypropan-2-yl) (9Z,12Z)-nonadeca-9,12-dienoate

(1-acetyloxy-3-hydroxypropan-2-yl) (9Z,12Z)-nonadeca-9,12-dienoate

C24H42O5 (410.3032)


   

(1-hydroxy-3-pentanoyloxypropan-2-yl) (9Z,12Z)-hexadeca-9,12-dienoate

(1-hydroxy-3-pentanoyloxypropan-2-yl) (9Z,12Z)-hexadeca-9,12-dienoate

C24H42O5 (410.3032)


   

1-Palmitoylglycerol 3-phosphate

1-Palmitoylglycerol 3-phosphate

C19H39O7P (410.2433)


A monoacylglycerol phosphate having palmitoyl as the acyl group on O-1 and with the phosphate group on O-3.

   

1-Palmitoyl-sn-glycerol 3-phosphate

1-Palmitoyl-sn-glycerol 3-phosphate

C19H39O7P (410.2433)


A 1-acyl-sn-glycerol 3-phosphate having palmitoyl as the acyl group.

   

e-Tokoferol

(2R)-3,4-dihydro-2,5,8-trimethyl-2-[(3E,7E)-4,8,12-trimethyl-3,7,11-tridecatrienyl]-2H-1-benzopyran-6-ol

C28H42O2 (410.3185)


A tocotrienol that is chroman-6-ol substituted by methyl groups at positions 2, 5 and 8 and a farnesyl chain at position 2. It has been isolated from various cultivars of wheat.

   

LysoPA(0:0/16:0)

LysoPA(0:0/16:0)

C19H39O7P (410.2433)


   

(3beta,22E,24R)-3-Hydroxyergosta-5,8,22-trien-7-one

(3beta,22E,24R)-3-Hydroxyergosta-5,8,22-trien-7-one

C28H42O2 (410.3185)


   

5,8-Epoxy-5,8-dihydro-10-apo-b,y-carotene-3,10-diol

5,8-Epoxy-5,8-dihydro-10-apo-b,y-carotene-3,10-diol

C27H38O3 (410.2821)


   

5,6-Epoxy-5,6-dihydro-10-apo-b,y-carotene-3,10-diol

5,6-Epoxy-5,6-dihydro-10-apo-b,y-carotene-3,10-diol

C27H38O3 (410.2821)


   

Gama-Tocotrienol

Gama-Tocotrienol

C28H42O2 (410.3185)


   

PGF2alpha-11-acetate methyl ester

PGF2alpha-11-acetate methyl ester

C23H38O6 (410.2668)


   

4Z,7Z,10Z,13Z,16Z,19Z,22Z-octacosaheptaenoic acid

4Z,7Z,10Z,13Z,16Z,19Z,22Z-octacosaheptaenoic acid

C28H42O2 (410.3185)


   

lysophosphatidic acid 16:0

lysophosphatidic acid 16:0

C19H39O7P (410.2433)


A lysophosphatidic acid in which the acyl group (position not specified) contains 16 carbons and no double bonds.

   

TG(20:2)

TG(4:0_6:0_10:2)

C23H38O6 (410.2668)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

DG(21:2)

DG(11:0_10:2)

C24H42O5 (410.3032)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

Octacosaheptaenoic acid

Octacosaheptaenoic acid

C28H42O2 (410.3185)


   

NA-Arg 17:1(9Z)

NA-Arg 17:1(9Z)

C22H42N4O3 (410.3257)


   

NA-Asn 19:1(9Z)

NA-Asn 19:1(9Z)

C23H42N2O4 (410.3144)


   

NA-Gln 18:1(9Z)

NA-Gln 18:1(9Z)

C23H42N2O4 (410.3144)


   

NA-Tryptamine 17:1(9Z)

NA-Tryptamine 17:1(9Z)

C27H42N2O (410.3297)


   

FAHFA 10:3/O-16:5

FAHFA 10:3/O-16:5

C26H34O4 (410.2457)


   

FAHFA 11:3/O-15:5

FAHFA 11:3/O-15:5

C26H34O4 (410.2457)


   

FAHFA 12:4/O-14:4

FAHFA 12:4/O-14:4

C26H34O4 (410.2457)


   

FAHFA 13:4/O-13:4

FAHFA 13:4/O-13:4

C26H34O4 (410.2457)


   

FAHFA 14:4/O-12:4

FAHFA 14:4/O-12:4

C26H34O4 (410.2457)


   

FAHFA 15:5/O-11:3

FAHFA 15:5/O-11:3

C26H34O4 (410.2457)


   

FAHFA 16:5/O-10:3

FAHFA 16:5/O-10:3

C26H34O4 (410.2457)


   

FAHFA 17:5/O-9:3

FAHFA 17:5/O-9:3

C26H34O4 (410.2457)


   

FAHFA 18:6/O-8:2

FAHFA 18:6/O-8:2

C26H34O4 (410.2457)


   

FAHFA 8:2/O-18:6

FAHFA 8:2/O-18:6

C26H34O4 (410.2457)


   

FAHFA 9:3/O-17:5

FAHFA 9:3/O-17:5

C26H34O4 (410.2457)


   
   
   

PA O-14:0/2:0

PA O-14:0/2:0

C19H39O7P (410.2433)


   
   
   
   
   
   
   
   
   

3-[(2,4b,8,8,10a-pentamethyl-4,4a,5,6,7,8a,9,10-octahydro-1h-phenanthren-1-yl)methyl]-4-hydroxybenzoic acid

3-[(2,4b,8,8,10a-pentamethyl-4,4a,5,6,7,8a,9,10-octahydro-1h-phenanthren-1-yl)methyl]-4-hydroxybenzoic acid

C27H38O3 (410.2821)


   

(13e)-2-oxatricyclo[20.2.2.1³,⁷]heptacosa-1(24),3,5,7(27),13,22,25-heptaene-5,24,25-triol

(13e)-2-oxatricyclo[20.2.2.1³,⁷]heptacosa-1(24),3,5,7(27),13,22,25-heptaene-5,24,25-triol

C26H34O4 (410.2457)


   

10-hydroxy-1,1,4a,6a,8,12b-hexamethyl-3h,4h,4bh,5h,6h,12h,12ah,13h,14h,14ah-naphtho[2,1-a]xanthen-2-one

10-hydroxy-1,1,4a,6a,8,12b-hexamethyl-3h,4h,4bh,5h,6h,12h,12ah,13h,14h,14ah-naphtho[2,1-a]xanthen-2-one

C27H38O3 (410.2821)


   

(1s,2s,5s,14s,15r,18r,19s)-10-hydroxy-5,15,19-trimethyl-6,21-dioxahexacyclo[17.3.3.0¹,¹⁸.0²,¹⁵.0⁵,¹⁴.0⁷,¹²]pentacosa-7,9,11-trien-20-one

(1s,2s,5s,14s,15r,18r,19s)-10-hydroxy-5,15,19-trimethyl-6,21-dioxahexacyclo[17.3.3.0¹,¹⁸.0²,¹⁵.0⁵,¹⁴.0⁷,¹²]pentacosa-7,9,11-trien-20-one

C26H34O4 (410.2457)


   

(1s,3as,3bs,9ar,9bs,11as)-1-[(2s)-2-hydroxy-6-methyl-5-methylideneheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,5h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one

(1s,3as,3bs,9ar,9bs,11as)-1-[(2s)-2-hydroxy-6-methyl-5-methylideneheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,5h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one

C28H42O2 (410.3185)


   

2-(6-hydroxy-4,8,12-trimethyltrideca-3,7,11-trien-1-yl)-2,8-dimethylchromen-6-ol

2-(6-hydroxy-4,8,12-trimethyltrideca-3,7,11-trien-1-yl)-2,8-dimethylchromen-6-ol

C27H38O3 (410.2821)


   

(2s)-6-methoxy-2,8-dimethyl-2-[(3e,7e)-4,8,12-trimethyltrideca-3,7,11-trien-1-yl]-3,4-dihydro-1-benzopyran

(2s)-6-methoxy-2,8-dimethyl-2-[(3e,7e)-4,8,12-trimethyltrideca-3,7,11-trien-1-yl]-3,4-dihydro-1-benzopyran

C28H42O2 (410.3185)


   

2-[(2e,6e,9r,10e)-9-hydroxy-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraen-1-yl]-6-methylcyclohexa-2,5-diene-1,4-dione

2-[(2e,6e,9r,10e)-9-hydroxy-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraen-1-yl]-6-methylcyclohexa-2,5-diene-1,4-dione

C27H38O3 (410.2821)


   

3-(3,7-dimethyloct-6-en-1-yl)-2-hydroxy-4-methoxy-6-(2-phenylethyl)benzoic acid

3-(3,7-dimethyloct-6-en-1-yl)-2-hydroxy-4-methoxy-6-(2-phenylethyl)benzoic acid

C26H34O4 (410.2457)


   

1-(2,5-dihydroxy-3-methylphenyl)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraen-5-one

1-(2,5-dihydroxy-3-methylphenyl)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraen-5-one

C27H38O3 (410.2821)


   

(2s,4as,4bs,6as,11as,11bs,13ar)-2-hydroxy-1,1,4a,6a,9,11b-hexamethyl-2h,3h,4h,4bh,5h,6h,11h,11ah,12h,13h,13ah-indeno[2,1-a]phenanthrene-7,10-dione

(2s,4as,4bs,6as,11as,11bs,13ar)-2-hydroxy-1,1,4a,6a,9,11b-hexamethyl-2h,3h,4h,4bh,5h,6h,11h,11ah,12h,13h,13ah-indeno[2,1-a]phenanthrene-7,10-dione

C27H38O3 (410.2821)


   

(1r,7s,9as,11ar)-1-[(2r,3e,5r)-5,6-dimethylhept-3-en-2-yl]-7-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,6h,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-4-one

(1r,7s,9as,11ar)-1-[(2r,3e,5r)-5,6-dimethylhept-3-en-2-yl]-7-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,6h,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-4-one

C28H42O2 (410.3185)


   

(1r,3ar,3br,9ar,9br,11ar)-1-[(2r,3e,5r)-5,6-dimethylhept-3-en-2-yl]-3b-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one

(1r,3ar,3br,9ar,9br,11ar)-1-[(2r,3e,5r)-5,6-dimethylhept-3-en-2-yl]-3b-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one

C28H42O2 (410.3185)


   

3-[(3z,6z)-14-(2,3-dihydroxyphenyl)tetradeca-3,6-dien-1-yl]benzene-1,2-diol

3-[(3z,6z)-14-(2,3-dihydroxyphenyl)tetradeca-3,6-dien-1-yl]benzene-1,2-diol

C26H34O4 (410.2457)


   

methyl 4,6-dimethyl-7-[3,6,8-trimethyl-7-oxo-2-(2-oxopropyl)-5,6,8,8a-tetrahydro-1h-naphthalen-1-yl]hepta-2,4,6-trienoate

methyl 4,6-dimethyl-7-[3,6,8-trimethyl-7-oxo-2-(2-oxopropyl)-5,6,8,8a-tetrahydro-1h-naphthalen-1-yl]hepta-2,4,6-trienoate

C26H34O4 (410.2457)


   

(2s,3r,4s,5r,6r)-2-{[(1ar,4r,4as,7r,7as,7bs)-1,1,4,7-tetramethyl-octahydro-1ah-cyclopropa[e]azulen-4-yl]oxy}-4,5-dihydroxy-6-methyloxan-3-yl acetate

(2s,3r,4s,5r,6r)-2-{[(1ar,4r,4as,7r,7as,7bs)-1,1,4,7-tetramethyl-octahydro-1ah-cyclopropa[e]azulen-4-yl]oxy}-4,5-dihydroxy-6-methyloxan-3-yl acetate

C23H38O6 (410.2668)


   

3-[5-(2,5,5,8a-tetramethyl-3,4,4a,6,7,8-hexahydronaphthalen-1-yl)-3-methylpent-2-en-1-yl]-4-hydroxybenzoic acid

3-[5-(2,5,5,8a-tetramethyl-3,4,4a,6,7,8-hexahydronaphthalen-1-yl)-3-methylpent-2-en-1-yl]-4-hydroxybenzoic acid

C27H38O3 (410.2821)


   

(2s,3r,4s,5r,6r)-2-({2-[(2r,4as)-4a,8-dimethyl-2,3,4,5,6,7-hexahydro-1h-naphthalen-2-yl]propan-2-yl}oxy)-4,5-dihydroxy-6-methyloxan-3-yl acetate

(2s,3r,4s,5r,6r)-2-({2-[(2r,4as)-4a,8-dimethyl-2,3,4,5,6,7-hexahydro-1h-naphthalen-2-yl]propan-2-yl}oxy)-4,5-dihydroxy-6-methyloxan-3-yl acetate

C23H38O6 (410.2668)


   

methyl 5-[7-(acetyloxy)-1,6-dihydroxy-2,5,5,8a-tetramethyl-hexahydro-2h-naphthalen-1-yl]-3-methylpent-2-enoate

methyl 5-[7-(acetyloxy)-1,6-dihydroxy-2,5,5,8a-tetramethyl-hexahydro-2h-naphthalen-1-yl]-3-methylpent-2-enoate

C23H38O6 (410.2668)


   

13-(6-hydroxy-2,8-dimethyl-3,4-dihydro-1-benzopyran-2-yl)-2,6,10-trimethyltrideca-2,6,10-trien-5-one

13-(6-hydroxy-2,8-dimethyl-3,4-dihydro-1-benzopyran-2-yl)-2,6,10-trimethyltrideca-2,6,10-trien-5-one

C27H38O3 (410.2821)


   

6β-hydroxyergosta-4,7,22-trien-3-one

NA

C28H42O2 (410.3185)


{"Ingredient_id": "HBIN012274","Ingredient_name": "6\u03b2-hydroxyergosta-4,7,22-trien-3-one","Alias": "NA","Ingredient_formula": "C28H42O2","Ingredient_Smile": "NA","Ingredient_weight": "410.63","OB_score": "25.38516555","CAS_id": "68378-35-8","SymMap_id": "SMIT12077","TCMID_id": "NA","TCMSP_id": "MOL011142","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

2-[(2e,6e,10z)-12-hydroxy-3,7-dimethyl-11-(4-methylpent-3-en-1-yl)dodeca-2,6,10-trien-1-yl]-5-methylcyclohexa-2,5-diene-1,4-dione

2-[(2e,6e,10z)-12-hydroxy-3,7-dimethyl-11-(4-methylpent-3-en-1-yl)dodeca-2,6,10-trien-1-yl]-5-methylcyclohexa-2,5-diene-1,4-dione

C27H38O3 (410.2821)


   

(9ar,11ar)-1-[(2r,3e,5r)-5,6-dimethylhept-3-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,5ah,6h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-5,7-dione

(9ar,11ar)-1-[(2r,3e,5r)-5,6-dimethylhept-3-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,5ah,6h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-5,7-dione

C28H42O2 (410.3185)


   

(3r,6s,9r,12s)-3,6,9-triisopropyl-12-(2-methylpropyl)-1,4,7,10-tetraazacyclododeca-1,4,7,10-tetraene-2,5,8,11-tetrol

(3r,6s,9r,12s)-3,6,9-triisopropyl-12-(2-methylpropyl)-1,4,7,10-tetraazacyclododeca-1,4,7,10-tetraene-2,5,8,11-tetrol

C21H38N4O4 (410.2893)


   

(1r,3ar,7s,9as,11ar)-1-[(2r,3e,5s)-5,6-dimethylhept-3-en-2-yl]-7-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,6h,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-4-one

(1r,3ar,7s,9as,11ar)-1-[(2r,3e,5s)-5,6-dimethylhept-3-en-2-yl]-7-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,6h,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-4-one

C28H42O2 (410.3185)


   

4-hydroxy-3-(3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraen-1-yl)benzoic acid

4-hydroxy-3-(3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraen-1-yl)benzoic acid

C27H38O3 (410.2821)


   

tricyclo[20.2.2.0²,⁷]hexacosa-1(24),2,4,6,11,22,25-heptaene-3,5,24,25-tetrol

tricyclo[20.2.2.0²,⁷]hexacosa-1(24),2,4,6,11,22,25-heptaene-3,5,24,25-tetrol

C26H34O4 (410.2457)


   

methyl (2e,4e,6e)-7-[(1r,6r,8s,8as)-3,6,8-trimethyl-7-oxo-2-(2-oxopropyl)-5,6,8,8a-tetrahydro-1h-naphthalen-1-yl]-4,6-dimethylhepta-2,4,6-trienoate

methyl (2e,4e,6e)-7-[(1r,6r,8s,8as)-3,6,8-trimethyl-7-oxo-2-(2-oxopropyl)-5,6,8,8a-tetrahydro-1h-naphthalen-1-yl]-4,6-dimethylhepta-2,4,6-trienoate

C26H34O4 (410.2457)


   

(1r,2r,4r,12r,13r,16z)-13-hydroxy-11,22-diazapentacyclo[11.11.2.1²,²².0²,¹².0⁴,¹¹]heptacosa-5,16,25-triene-25-carbaldehyde

(1r,2r,4r,12r,13r,16z)-13-hydroxy-11,22-diazapentacyclo[11.11.2.1²,²².0²,¹².0⁴,¹¹]heptacosa-5,16,25-triene-25-carbaldehyde

C26H38N2O2 (410.2933)


   

(1r,2r,3s,5s,8r,10r,11r,15r,16s)-15-(furan-3-yl)-10-hydroxy-2,7,7,11,16-pentamethyl-4-oxapentacyclo[9.7.0.0²,⁸.0³,⁵.0¹²,¹⁶]octadec-12-en-6-one

(1r,2r,3s,5s,8r,10r,11r,15r,16s)-15-(furan-3-yl)-10-hydroxy-2,7,7,11,16-pentamethyl-4-oxapentacyclo[9.7.0.0²,⁸.0³,⁵.0¹²,¹⁶]octadec-12-en-6-one

C26H34O4 (410.2457)


   

(2e,7e)-10-[(2r)-6-hydroxy-2,8-dimethyl-3,4-dihydro-1-benzopyran-2-yl]-3,7-dimethyl-2-(2-methylprop-1-en-1-yl)deca-2,7-dienal

(2e,7e)-10-[(2r)-6-hydroxy-2,8-dimethyl-3,4-dihydro-1-benzopyran-2-yl]-3,7-dimethyl-2-(2-methylprop-1-en-1-yl)deca-2,7-dienal

C27H38O3 (410.2821)


   

1-(2-hydroxy-6-methyl-5-methylideneheptan-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,5h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one

1-(2-hydroxy-6-methyl-5-methylideneheptan-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,5h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one

C28H42O2 (410.3185)


   

2-[12-hydroxy-3,7-dimethyl-11-(4-methylpent-3-en-1-yl)dodeca-2,6,10-trien-1-yl]-5-methylcyclohexa-2,5-diene-1,4-dione

2-[12-hydroxy-3,7-dimethyl-11-(4-methylpent-3-en-1-yl)dodeca-2,6,10-trien-1-yl]-5-methylcyclohexa-2,5-diene-1,4-dione

C27H38O3 (410.2821)


   

(4s,4ar,5s,7r,8r,8as)-2,5,8-trihydroxy-4-(3-hydroxypropanoyl)-4,7-dimethyl-3-[(2r)-octan-2-yl]-4a,5,6,7,8,8a-hexahydronaphthalen-1-one

(4s,4ar,5s,7r,8r,8as)-2,5,8-trihydroxy-4-(3-hydroxypropanoyl)-4,7-dimethyl-3-[(2r)-octan-2-yl]-4a,5,6,7,8,8a-hexahydronaphthalen-1-one

C23H38O6 (410.2668)


   

2-(8-hydroxy-4,8,12-trimethyltrideca-3,6,11-trien-1-yl)-2,8-dimethylchromen-6-ol

2-(8-hydroxy-4,8,12-trimethyltrideca-3,6,11-trien-1-yl)-2,8-dimethylchromen-6-ol

C27H38O3 (410.2821)


   

methyl (2s,3e,5r)-5-[(1r,3as,3bs,9ar,9bs,11ar)-9a,11a-dimethyl-7-oxo-1h,2h,3h,3ah,3bh,4h,5h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-2-methylhex-3-enoate

methyl (2s,3e,5r)-5-[(1r,3as,3bs,9ar,9bs,11ar)-9a,11a-dimethyl-7-oxo-1h,2h,3h,3ah,3bh,4h,5h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-2-methylhex-3-enoate

C27H38O3 (410.2821)


   

3-{[(1r,4as,4bs,8as,10ar)-2,4b,8,8,10a-pentamethyl-4,4a,5,6,7,8a,9,10-octahydro-1h-phenanthren-1-yl]methyl}-4-hydroxybenzoic acid

3-{[(1r,4as,4bs,8as,10ar)-2,4b,8,8,10a-pentamethyl-4,4a,5,6,7,8a,9,10-octahydro-1h-phenanthren-1-yl]methyl}-4-hydroxybenzoic acid

C27H38O3 (410.2821)


   

(3r,3ar,5r,8s,11br)-3-[(2s,3e,5s)-5,6-dimethylhept-3-en-2-yl]-3a,6-dimethyl-1h,2h,3h,4h,5h,7h,8h,9h,10h,11bh-cyclopenta[a]anthracene-5,8-diol

(3r,3ar,5r,8s,11br)-3-[(2s,3e,5s)-5,6-dimethylhept-3-en-2-yl]-3a,6-dimethyl-1h,2h,3h,4h,5h,7h,8h,9h,10h,11bh-cyclopenta[a]anthracene-5,8-diol

C28H42O2 (410.3185)


   

15-(furan-3-yl)-10-hydroxy-2,7,7,11,16-pentamethyl-6-oxatetracyclo[9.7.0.0²,⁸.0¹²,¹⁶]octadeca-3,12-dien-5-one

15-(furan-3-yl)-10-hydroxy-2,7,7,11,16-pentamethyl-6-oxatetracyclo[9.7.0.0²,⁸.0¹²,¹⁶]octadeca-3,12-dien-5-one

C26H34O4 (410.2457)


   

(1r,2r,4r,5z,12r,13s,16z)-13-hydroxy-11,22-diazapentacyclo[11.11.2.1²,²².0²,¹².0⁴,¹¹]heptacosa-5,16,25-triene-25-carbaldehyde

(1r,2r,4r,5z,12r,13s,16z)-13-hydroxy-11,22-diazapentacyclo[11.11.2.1²,²².0²,¹².0⁴,¹¹]heptacosa-5,16,25-triene-25-carbaldehyde

C26H38N2O2 (410.2933)


   

methyl (2e)-5-[(1s,2r,4as,6s,7r,8as)-7-(acetyloxy)-1,6-dihydroxy-2,5,5,8a-tetramethyl-hexahydro-2h-naphthalen-1-yl]-3-methylpent-2-enoate

methyl (2e)-5-[(1s,2r,4as,6s,7r,8as)-7-(acetyloxy)-1,6-dihydroxy-2,5,5,8a-tetramethyl-hexahydro-2h-naphthalen-1-yl]-3-methylpent-2-enoate

C23H38O6 (410.2668)


   

(4ar,4br,6as,12as,12br,14ar)-10-hydroxy-1,1,4a,6a,8,12b-hexamethyl-3h,4h,4bh,5h,6h,12h,12ah,13h,14h,14ah-naphtho[2,1-a]xanthen-2-one

(4ar,4br,6as,12as,12br,14ar)-10-hydroxy-1,1,4a,6a,8,12b-hexamethyl-3h,4h,4bh,5h,6h,12h,12ah,13h,14h,14ah-naphtho[2,1-a]xanthen-2-one

C27H38O3 (410.2821)


   

10-hydroxy-5,15,19-trimethyl-6,21-dioxahexacyclo[17.3.3.0¹,¹⁸.0²,¹⁵.0⁵,¹⁴.0⁷,¹²]pentacosa-7,9,11-trien-20-one

10-hydroxy-5,15,19-trimethyl-6,21-dioxahexacyclo[17.3.3.0¹,¹⁸.0²,¹⁵.0⁵,¹⁴.0⁷,¹²]pentacosa-7,9,11-trien-20-one

C26H34O4 (410.2457)


   

(1s,2s,3r,4r,5r,7s,8r,11s,14r,15r,17s)-15-hydroxy-14-methoxy-5,8,11,15-tetramethyl-10,18-dioxatetracyclo[9.7.0.0²,⁷.0³,¹⁷]octadecan-4-yl acetate

(1s,2s,3r,4r,5r,7s,8r,11s,14r,15r,17s)-15-hydroxy-14-methoxy-5,8,11,15-tetramethyl-10,18-dioxatetracyclo[9.7.0.0²,⁷.0³,¹⁷]octadecan-4-yl acetate

C23H38O6 (410.2668)


   

(2e,6z,10e)-1-(2,5-dihydroxy-3-methylphenyl)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraen-5-one

(2e,6z,10e)-1-(2,5-dihydroxy-3-methylphenyl)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraen-5-one

C27H38O3 (410.2821)


   

(1r,3ar,7s,9as,11ar)-1-[(2r,3e,5r)-5,6-dimethylhept-3-en-2-yl]-7-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,6h,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-4-one

(1r,3ar,7s,9as,11ar)-1-[(2r,3e,5r)-5,6-dimethylhept-3-en-2-yl]-7-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,6h,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-4-one

C28H42O2 (410.3185)


   

2-hydroxy-1,1,4a,6a,9,11b-hexamethyl-2h,3h,4h,4bh,5h,6h,11h,11ah,12h,13h,13ah-indeno[2,1-a]phenanthrene-7,10-dione

2-hydroxy-1,1,4a,6a,9,11b-hexamethyl-2h,3h,4h,4bh,5h,6h,11h,11ah,12h,13h,13ah-indeno[2,1-a]phenanthrene-7,10-dione

C27H38O3 (410.2821)


   

2-oxatricyclo[20.2.2.1³,⁷]heptacosa-1(24),3,5,7(27),13,22,25-heptaene-5,24,25-triol

2-oxatricyclo[20.2.2.1³,⁷]heptacosa-1(24),3,5,7(27),13,22,25-heptaene-5,24,25-triol

C26H34O4 (410.2457)


   

(1's,2r,2's,4's,5r,7's,8'r,9's,12's,13'r)-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosane]-14',17'-dien-16'-one

(1's,2r,2's,4's,5r,7's,8'r,9's,12's,13'r)-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosane]-14',17'-dien-16'-one

C27H38O3 (410.2821)


   

3,5-bis[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-4-hydroxybenzoic acid

3,5-bis[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-4-hydroxybenzoic acid

C27H38O3 (410.2821)


   

17,19-dihydroxy-4,8,12-trimethyl-14-(2-methylprop-1-en-1-yl)bicyclo[13.2.2]nonadeca-1(17),3,7,11,15(19)-pentaene-16,18-dione

17,19-dihydroxy-4,8,12-trimethyl-14-(2-methylprop-1-en-1-yl)bicyclo[13.2.2]nonadeca-1(17),3,7,11,15(19)-pentaene-16,18-dione

C26H34O4 (410.2457)


   

tricyclo[20.2.2.0²,⁷]hexacosa-1(24),2,4,6,13,22,25-heptaene-3,5,24,25-tetrol

tricyclo[20.2.2.0²,⁷]hexacosa-1(24),2,4,6,13,22,25-heptaene-3,5,24,25-tetrol

C26H34O4 (410.2457)


   

2,6,11,14-tetramethyl-5-propyl-4,13,19,20-tetraoxatricyclo[14.2.1.1⁷,¹⁰]icosane-3,12-dione

2,6,11,14-tetramethyl-5-propyl-4,13,19,20-tetraoxatricyclo[14.2.1.1⁷,¹⁰]icosane-3,12-dione

C23H38O6 (410.2668)


   

(1r,3ar,7s,9as,11ar)-1-[(2r,3e,5r)-5,6-dimethylhept-3-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,6h,7h,8h,9h,11h-cyclopenta[a]phenanthrene-7-peroxol

(1r,3ar,7s,9as,11ar)-1-[(2r,3e,5r)-5,6-dimethylhept-3-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,6h,7h,8h,9h,11h-cyclopenta[a]phenanthrene-7-peroxol

C28H42O2 (410.3185)


   

methyl 5-{9a,11a-dimethyl-7-oxo-1h,2h,3h,3ah,3bh,4h,5h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}-2-methylhex-3-enoate

methyl 5-{9a,11a-dimethyl-7-oxo-1h,2h,3h,3ah,3bh,4h,5h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}-2-methylhex-3-enoate

C27H38O3 (410.2821)


   

3,5-bis(3,7-dimethylocta-2,6-dien-1-yl)-4-hydroxybenzoic acid

3,5-bis(3,7-dimethylocta-2,6-dien-1-yl)-4-hydroxybenzoic acid

C27H38O3 (410.2821)


   

(6e,10e)-13-[(2r)-6-hydroxy-2,8-dimethyl-3,4-dihydro-1-benzopyran-2-yl]-2,6,10-trimethyltrideca-2,6,10-trien-5-one

(6e,10e)-13-[(2r)-6-hydroxy-2,8-dimethyl-3,4-dihydro-1-benzopyran-2-yl]-2,6,10-trimethyltrideca-2,6,10-trien-5-one

C27H38O3 (410.2821)


   

15-(furan-3-yl)-10-hydroxy-2,7,7,11,16-pentamethyl-4-oxapentacyclo[9.7.0.0²,⁸.0³,⁵.0¹²,¹⁶]octadec-12-en-6-one

15-(furan-3-yl)-10-hydroxy-2,7,7,11,16-pentamethyl-4-oxapentacyclo[9.7.0.0²,⁸.0³,⁵.0¹²,¹⁶]octadec-12-en-6-one

C26H34O4 (410.2457)


   

1-{15-hydroxy-5-methyl-19-oxapentacyclo[12.3.2.0¹,¹³.0²,¹⁰.0⁵,⁹]nonadeca-6,10-dien-6-yl}-5-methyl-4-methylidenehexan-1-one

1-{15-hydroxy-5-methyl-19-oxapentacyclo[12.3.2.0¹,¹³.0²,¹⁰.0⁵,⁹]nonadeca-6,10-dien-6-yl}-5-methyl-4-methylidenehexan-1-one

C27H38O3 (410.2821)


   

(2r,7r)-1-(acetyloxy)-7-methyl-3-methylidene-10-[(2s)-2,6,6-trimethyloxan-2-yl]decan-2-yl acetate

(2r,7r)-1-(acetyloxy)-7-methyl-3-methylidene-10-[(2s)-2,6,6-trimethyloxan-2-yl]decan-2-yl acetate

C24H42O5 (410.3032)


   

1-(5,6-dimethylhept-3-en-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-5,7-dione

1-(5,6-dimethylhept-3-en-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-5,7-dione

C28H42O2 (410.3185)


   

(3e,7z,11e,14s)-17,19-dihydroxy-4,8,12-trimethyl-14-(2-methylprop-1-en-1-yl)bicyclo[13.2.2]nonadeca-1(17),3,7,11,15(19)-pentaene-16,18-dione

(3e,7z,11e,14s)-17,19-dihydroxy-4,8,12-trimethyl-14-(2-methylprop-1-en-1-yl)bicyclo[13.2.2]nonadeca-1(17),3,7,11,15(19)-pentaene-16,18-dione

C26H34O4 (410.2457)


   

(1s,2s,5s,14s,15r,18r,19r)-10-hydroxy-5,15,19-trimethyl-6,21-dioxahexacyclo[17.3.3.0¹,¹⁸.0²,¹⁵.0⁵,¹⁴.0⁷,¹²]pentacosa-7,9,11-trien-20-one

(1s,2s,5s,14s,15r,18r,19r)-10-hydroxy-5,15,19-trimethyl-6,21-dioxahexacyclo[17.3.3.0¹,¹⁸.0²,¹⁵.0⁵,¹⁴.0⁷,¹²]pentacosa-7,9,11-trien-20-one

C26H34O4 (410.2457)


   

(2s)-6-methoxy-2,8-dimethyl-2-(4,8,12-trimethyltrideca-3,7,11-trien-1-yl)-3,4-dihydro-1-benzopyran

(2s)-6-methoxy-2,8-dimethyl-2-(4,8,12-trimethyltrideca-3,7,11-trien-1-yl)-3,4-dihydro-1-benzopyran

C28H42O2 (410.3185)


   

2-[15-(acetyloxy)pentadecyl]-4-methylidene-5-oxooxolane-3-carboxylic acid

2-[15-(acetyloxy)pentadecyl]-4-methylidene-5-oxooxolane-3-carboxylic acid

C23H38O6 (410.2668)


   

3-[(3r)-3,7-dimethyloct-6-en-1-yl]-2-hydroxy-4-methoxy-6-(2-phenylethyl)benzoic acid

3-[(3r)-3,7-dimethyloct-6-en-1-yl]-2-hydroxy-4-methoxy-6-(2-phenylethyl)benzoic acid

C26H34O4 (410.2457)


   

2-[(2e,6e)-12-hydroxy-3,7-dimethyl-11-(4-methylpent-3-en-1-yl)dodeca-2,6,10-trien-1-yl]-5-methylcyclohexa-2,5-diene-1,4-dione

2-[(2e,6e)-12-hydroxy-3,7-dimethyl-11-(4-methylpent-3-en-1-yl)dodeca-2,6,10-trien-1-yl]-5-methylcyclohexa-2,5-diene-1,4-dione

C27H38O3 (410.2821)


   

(1s,2s,5s,6r,7s,10r,11s,14r,16r)-2,6,11,14-tetramethyl-5-propyl-4,13,19,20-tetraoxatricyclo[14.2.1.1⁷,¹⁰]icosane-3,12-dione

(1s,2s,5s,6r,7s,10r,11s,14r,16r)-2,6,11,14-tetramethyl-5-propyl-4,13,19,20-tetraoxatricyclo[14.2.1.1⁷,¹⁰]icosane-3,12-dione

C23H38O6 (410.2668)


   

1-[(1s,4ar,4br,6as,12as,12br,14ar)-10-hydroxy-1,4a,6a,12b-tetramethyl-2h,3h,4h,4bh,5h,6h,12h,12ah,13h,14h,14ah-naphtho[2,1-a]xanthen-1-yl]ethanone

1-[(1s,4ar,4br,6as,12as,12br,14ar)-10-hydroxy-1,4a,6a,12b-tetramethyl-2h,3h,4h,4bh,5h,6h,12h,12ah,13h,14h,14ah-naphtho[2,1-a]xanthen-1-yl]ethanone

C27H38O3 (410.2821)


   

methyl (3e,5r)-5-[(1r,3as,3bs,9ar,9bs,11ar)-9a,11a-dimethyl-7-oxo-1h,2h,3h,3ah,3bh,4h,5h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-2-methylhex-3-enoate

methyl (3e,5r)-5-[(1r,3as,3bs,9ar,9bs,11ar)-9a,11a-dimethyl-7-oxo-1h,2h,3h,3ah,3bh,4h,5h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-2-methylhex-3-enoate

C27H38O3 (410.2821)


   

9a,11a-dimethyl-1-[(2r)-6-methyl-5-oxohept-6-en-2-yl]-1h,2h,3h,3ah,3bh,4h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-5,7-dione

9a,11a-dimethyl-1-[(2r)-6-methyl-5-oxohept-6-en-2-yl]-1h,2h,3h,3ah,3bh,4h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-5,7-dione

C27H38O3 (410.2821)


   

(2s)-2,6,7-trimethyl-2-[(3e,7e)-4,8,12-trimethyltrideca-3,7,11-trien-1-yl]-3,4-dihydro-1-benzopyran-8-ol

(2s)-2,6,7-trimethyl-2-[(3e,7e)-4,8,12-trimethyltrideca-3,7,11-trien-1-yl]-3,4-dihydro-1-benzopyran-8-ol

C28H42O2 (410.3185)


   

(1s,2s,4ar,8as)-2-isopropyl-4a-methyl-8-methylidene-octahydronaphthalen-1-yl 3-[4-(acetyloxy)phenyl]prop-2-enoate

(1s,2s,4ar,8as)-2-isopropyl-4a-methyl-8-methylidene-octahydronaphthalen-1-yl 3-[4-(acetyloxy)phenyl]prop-2-enoate

C26H34O4 (410.2457)


   

(3e,7e,11e,14s)-17,19-dihydroxy-4,8,12-trimethyl-14-(2-methylprop-1-en-1-yl)bicyclo[13.2.2]nonadeca-1(17),3,7,11,15(19)-pentaene-16,18-dione

(3e,7e,11e,14s)-17,19-dihydroxy-4,8,12-trimethyl-14-(2-methylprop-1-en-1-yl)bicyclo[13.2.2]nonadeca-1(17),3,7,11,15(19)-pentaene-16,18-dione

C26H34O4 (410.2457)


   

3-[(1r,2r,3s,4as,6r,8r,8as)-2-[(2r)-butan-2-yl]-3,6-dihydroxy-1,3,6,8-tetramethyl-4-oxo-hexahydronaphthalen-1-yl]-3-oxopropyl acetate

3-[(1r,2r,3s,4as,6r,8r,8as)-2-[(2r)-butan-2-yl]-3,6-dihydroxy-1,3,6,8-tetramethyl-4-oxo-hexahydronaphthalen-1-yl]-3-oxopropyl acetate

C23H38O6 (410.2668)


   

octacosa-4,7,10,13,16,19,22-heptaenoic acid

octacosa-4,7,10,13,16,19,22-heptaenoic acid

C28H42O2 (410.3185)


   

(1r,2s,3r,4r,5r,7s,8s,11r,14r,15r,17r)-15-hydroxy-14-methoxy-5,8,11,15-tetramethyl-10,18-dioxatetracyclo[9.7.0.0²,⁷.0³,¹⁷]octadecan-4-yl acetate

(1r,2s,3r,4r,5r,7s,8s,11r,14r,15r,17r)-15-hydroxy-14-methoxy-5,8,11,15-tetramethyl-10,18-dioxatetracyclo[9.7.0.0²,⁷.0³,¹⁷]octadecan-4-yl acetate

C23H38O6 (410.2668)


   

1-(acetyloxy)-7-methyl-3-methylidene-10-(2,6,6-trimethyloxan-2-yl)decan-2-yl acetate

1-(acetyloxy)-7-methyl-3-methylidene-10-(2,6,6-trimethyloxan-2-yl)decan-2-yl acetate

C24H42O5 (410.3032)


   

(2r)-2-[(3e,6r,7e)-6-hydroxy-4,8,12-trimethyltrideca-3,7,11-trien-1-yl]-2,8-dimethylchromen-6-ol

(2r)-2-[(3e,6r,7e)-6-hydroxy-4,8,12-trimethyltrideca-3,7,11-trien-1-yl]-2,8-dimethylchromen-6-ol

C27H38O3 (410.2821)


   

(13e)-tricyclo[20.2.2.0²,⁷]hexacosa-1(24),2,4,6,13,22,25-heptaene-3,5,24,25-tetrol

(13e)-tricyclo[20.2.2.0²,⁷]hexacosa-1(24),2,4,6,13,22,25-heptaene-3,5,24,25-tetrol

C26H34O4 (410.2457)


   

(4ar,4br,8as,9r,10ar)-2-(3-hydroxy-4-methylphenyl)-4b,8,8,10a-tetramethyl-4,4a,5,6,7,8a,9,10-octahydro-1h-phenanthren-9-yl acetate

(4ar,4br,8as,9r,10ar)-2-(3-hydroxy-4-methylphenyl)-4b,8,8,10a-tetramethyl-4,4a,5,6,7,8a,9,10-octahydro-1h-phenanthren-9-yl acetate

C27H38O3 (410.2821)


   

1-[(1s,2s,5s,9s,13r,14r,15s)-15-hydroxy-5-methyl-19-oxapentacyclo[12.3.2.0¹,¹³.0²,¹⁰.0⁵,⁹]nonadeca-6,10-dien-6-yl]-5-methyl-4-methylidenehexan-1-one

1-[(1s,2s,5s,9s,13r,14r,15s)-15-hydroxy-5-methyl-19-oxapentacyclo[12.3.2.0¹,¹³.0²,¹⁰.0⁵,⁹]nonadeca-6,10-dien-6-yl]-5-methyl-4-methylidenehexan-1-one

C27H38O3 (410.2821)


   

4-hydroxy-5-methyl-3-[(2e,6e,10e)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraen-1-yl]cyclohexa-3,5-diene-1,2-dione

4-hydroxy-5-methyl-3-[(2e,6e,10e)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraen-1-yl]cyclohexa-3,5-diene-1,2-dione

C27H38O3 (410.2821)


   

(1r,5ar,7s,9as,11ar)-7-hydroxy-9a,11a-dimethyl-1-[(2r)-6-methyl-5-methylideneheptan-2-yl]-1h,2h,5h,5ah,6h,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-4-one

(1r,5ar,7s,9as,11ar)-7-hydroxy-9a,11a-dimethyl-1-[(2r)-6-methyl-5-methylideneheptan-2-yl]-1h,2h,5h,5ah,6h,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-4-one

C28H42O2 (410.3185)


   

(1r)-1-isopropyl-4-methylcyclohex-3-en-1-yl 4-hydroxy-3,5-bis(3-methylbut-2-en-1-yl)benzoate

(1r)-1-isopropyl-4-methylcyclohex-3-en-1-yl 4-hydroxy-3,5-bis(3-methylbut-2-en-1-yl)benzoate

C27H38O3 (410.2821)


   

1-(5,6-dimethylhept-3-en-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,6h,7h,8h,9h,11h-cyclopenta[a]phenanthrene-7-peroxol

1-(5,6-dimethylhept-3-en-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,6h,7h,8h,9h,11h-cyclopenta[a]phenanthrene-7-peroxol

C28H42O2 (410.3185)


   

3-{5-[(4as,8as)-2,5,5,8a-tetramethyl-3,4,4a,6,7,8-hexahydronaphthalen-1-yl]-3-methylpent-2-en-1-yl}-4-hydroxybenzoic acid

3-{5-[(4as,8as)-2,5,5,8a-tetramethyl-3,4,4a,6,7,8-hexahydronaphthalen-1-yl]-3-methylpent-2-en-1-yl}-4-hydroxybenzoic acid

C27H38O3 (410.2821)


   

(1s,2s,5r,6r,9s,10s,15s,19s)-5-methyl-6-[(2r)-6-methyl-5-methylideneheptan-2-yl]-16-oxapentacyclo[13.2.2.0¹,¹³.0²,¹⁰.0⁵,⁹]nonadeca-11,13-dien-19-ol

(1s,2s,5r,6r,9s,10s,15s,19s)-5-methyl-6-[(2r)-6-methyl-5-methylideneheptan-2-yl]-16-oxapentacyclo[13.2.2.0¹,¹³.0²,¹⁰.0⁵,⁹]nonadeca-11,13-dien-19-ol

C28H42O2 (410.3185)


   

(2e,10e)-1-(2,5-dihydroxy-3-methylphenyl)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraen-5-one

(2e,10e)-1-(2,5-dihydroxy-3-methylphenyl)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraen-5-one

C27H38O3 (410.2821)


   

4-hydroxy-3-[(2e,6e,10e)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraen-1-yl]benzoic acid

4-hydroxy-3-[(2e,6e,10e)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraen-1-yl]benzoic acid

C27H38O3 (410.2821)


   

(2e,6e,10e)-13-[(2s)-6-hydroxy-2,8-dimethyl-3,4-dihydro-1-benzopyran-2-yl]-2,6,10-trimethyltrideca-2,6,10-trienal

(2e,6e,10e)-13-[(2s)-6-hydroxy-2,8-dimethyl-3,4-dihydro-1-benzopyran-2-yl]-2,6,10-trimethyltrideca-2,6,10-trienal

C27H38O3 (410.2821)


   

(1r,2r,4r,5z,13s,16z)-13-hydroxy-11,22-diazapentacyclo[11.11.2.1²,²².0²,¹².0⁴,¹¹]heptacosa-5,16,25-triene-25-carbaldehyde

(1r,2r,4r,5z,13s,16z)-13-hydroxy-11,22-diazapentacyclo[11.11.2.1²,²².0²,¹².0⁴,¹¹]heptacosa-5,16,25-triene-25-carbaldehyde

C26H38N2O2 (410.2933)


   

(4as,11as,11bs,13ar)-2-hydroxy-1,1,4a,6a,9,11b-hexamethyl-2h,3h,4h,4bh,5h,6h,11h,11ah,12h,13h,13ah-indeno[2,1-a]phenanthrene-7,10-dione

(4as,11as,11bs,13ar)-2-hydroxy-1,1,4a,6a,9,11b-hexamethyl-2h,3h,4h,4bh,5h,6h,11h,11ah,12h,13h,13ah-indeno[2,1-a]phenanthrene-7,10-dione

C27H38O3 (410.2821)


   

1-(5,6-dimethylhept-3-en-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,5ah,6h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-5,7-dione

1-(5,6-dimethylhept-3-en-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,5ah,6h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-5,7-dione

C28H42O2 (410.3185)


   

(1r,2r,8s,10r,11r,15r,16s)-15-(furan-3-yl)-10-hydroxy-2,7,7,11,16-pentamethyl-6-oxatetracyclo[9.7.0.0²,⁸.0¹²,¹⁶]octadeca-3,12-dien-5-one

(1r,2r,8s,10r,11r,15r,16s)-15-(furan-3-yl)-10-hydroxy-2,7,7,11,16-pentamethyl-6-oxatetracyclo[9.7.0.0²,⁸.0¹²,¹⁶]octadeca-3,12-dien-5-one

C26H34O4 (410.2457)


   

2-{[2-(4a,8-dimethyl-2,3,4,5,6,7-hexahydro-1h-naphthalen-2-yl)propan-2-yl]oxy}-4,5-dihydroxy-6-methyloxan-3-yl acetate

2-{[2-(4a,8-dimethyl-2,3,4,5,6,7-hexahydro-1h-naphthalen-2-yl)propan-2-yl]oxy}-4,5-dihydroxy-6-methyloxan-3-yl acetate

C23H38O6 (410.2668)


   

(4r,7z,11z,15z)-19-hydroxy-3,3,7,11,15-pentamethyl-2-oxatricyclo[16.3.1.0⁴,²¹]docosa-1(21),7,11,15,18-pentaene-20,22-dione

(4r,7z,11z,15z)-19-hydroxy-3,3,7,11,15-pentamethyl-2-oxatricyclo[16.3.1.0⁴,²¹]docosa-1(21),7,11,15,18-pentaene-20,22-dione

C26H34O4 (410.2457)


   

(2e,6e,10e)-1-(2,5-dihydroxy-3-methylphenyl)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraen-5-one

(2e,6e,10e)-1-(2,5-dihydroxy-3-methylphenyl)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraen-5-one

C27H38O3 (410.2821)


   

2-hydroxy-5-methyl-3-[(2e,6e,10e)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraen-1-yl]cyclohexa-2,5-diene-1,4-dione

2-hydroxy-5-methyl-3-[(2e,6e,10e)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraen-1-yl]cyclohexa-2,5-diene-1,4-dione

C27H38O3 (410.2821)


   

(1r,3ar,7s,9as,11ar)-1-[(2s,3e,5s)-5,6-dimethylhept-3-en-2-yl]-7-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,6h,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-4-one

(1r,3ar,7s,9as,11ar)-1-[(2s,3e,5s)-5,6-dimethylhept-3-en-2-yl]-7-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,6h,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-4-one

C28H42O2 (410.3185)


   

(3z,7z,11z,14s)-17,19-dihydroxy-4,8,12-trimethyl-14-(2-methylprop-1-en-1-yl)bicyclo[13.2.2]nonadeca-1(17),3,7,11,15(19)-pentaene-16,18-dione

(3z,7z,11z,14s)-17,19-dihydroxy-4,8,12-trimethyl-14-(2-methylprop-1-en-1-yl)bicyclo[13.2.2]nonadeca-1(17),3,7,11,15(19)-pentaene-16,18-dione

C26H34O4 (410.2457)


   

(2e,6e,10e)-13-(6-hydroxy-2,8-dimethyl-3,4-dihydro-1-benzopyran-2-yl)-2,6,10-trimethyltrideca-2,6,10-trienal

(2e,6e,10e)-13-(6-hydroxy-2,8-dimethyl-3,4-dihydro-1-benzopyran-2-yl)-2,6,10-trimethyltrideca-2,6,10-trienal

C27H38O3 (410.2821)


   

1-(2,4,6-trihydroxyphenyl)icosa-5,8,11,14,17-pentaen-1-one

1-(2,4,6-trihydroxyphenyl)icosa-5,8,11,14,17-pentaen-1-one

C26H34O4 (410.2457)


   

15-hydroxy-14-methoxy-5,8,11,15-tetramethyl-10,18-dioxatetracyclo[9.7.0.0²,⁷.0³,¹⁷]octadecan-4-yl acetate

15-hydroxy-14-methoxy-5,8,11,15-tetramethyl-10,18-dioxatetracyclo[9.7.0.0²,⁷.0³,¹⁷]octadecan-4-yl acetate

C23H38O6 (410.2668)


   

(13z)-tricyclo[20.2.2.0²,⁷]hexacosa-1(24),2,4,6,13,22,25-heptaene-3,5,24,25-tetrol

(13z)-tricyclo[20.2.2.0²,⁷]hexacosa-1(24),2,4,6,13,22,25-heptaene-3,5,24,25-tetrol

C26H34O4 (410.2457)


   

3-{[(1s,4as,5r,8as)-2,5,8a-trimethyl-5-(4-methylpent-3-en-1-yl)-1,4,4a,6,7,8-hexahydronaphthalen-1-yl]methyl}-4-hydroxybenzoic acid

3-{[(1s,4as,5r,8as)-2,5,8a-trimethyl-5-(4-methylpent-3-en-1-yl)-1,4,4a,6,7,8-hexahydronaphthalen-1-yl]methyl}-4-hydroxybenzoic acid

C27H38O3 (410.2821)


   

13-(6-hydroxy-2,8-dimethyl-3,4-dihydro-1-benzopyran-2-yl)-2,6,10-trimethyltrideca-2,6,10-trienal

13-(6-hydroxy-2,8-dimethyl-3,4-dihydro-1-benzopyran-2-yl)-2,6,10-trimethyltrideca-2,6,10-trienal

C27H38O3 (410.2821)


   

2-(9-hydroxy-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraen-1-yl)-6-methylcyclohexa-2,5-diene-1,4-dione

2-(9-hydroxy-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraen-1-yl)-6-methylcyclohexa-2,5-diene-1,4-dione

C27H38O3 (410.2821)


   

3-{[(1r,4ar,5s,8ar)-5,8a-dimethyl-2-methylidene-5-(4-methylpent-4-en-1-yl)-hexahydro-1h-naphthalen-1-yl]methyl}-4-hydroxybenzoic acid

3-{[(1r,4ar,5s,8ar)-5,8a-dimethyl-2-methylidene-5-(4-methylpent-4-en-1-yl)-hexahydro-1h-naphthalen-1-yl]methyl}-4-hydroxybenzoic acid

C27H38O3 (410.2821)


   

(1r,3as,3bs,9ar,9bs,11ar)-1-[(2r,3e,5r)-5,6-dimethylhept-3-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-5,7-dione

(1r,3as,3bs,9ar,9bs,11ar)-1-[(2r,3e,5r)-5,6-dimethylhept-3-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-5,7-dione

C28H42O2 (410.3185)


   

2-{6-[2-(8a-hydroxy-1,2,5,5-tetramethyl-hexahydro-2h-naphthalen-1-yl)ethyl]-6-methyl-1,2-dioxan-3-yl}propanoic acid

2-{6-[2-(8a-hydroxy-1,2,5,5-tetramethyl-hexahydro-2h-naphthalen-1-yl)ethyl]-6-methyl-1,2-dioxan-3-yl}propanoic acid

C24H42O5 (410.3032)


   

2,5,8-trihydroxy-4-(3-hydroxypropanoyl)-4,7-dimethyl-3-(octan-2-yl)-4a,5,6,7,8,8a-hexahydronaphthalen-1-one

2,5,8-trihydroxy-4-(3-hydroxypropanoyl)-4,7-dimethyl-3-(octan-2-yl)-4a,5,6,7,8,8a-hexahydronaphthalen-1-one

C23H38O6 (410.2668)


   

(1s,2r,5s,14s,15r,18r,19s)-10-hydroxy-5,15,19-trimethyl-6,21-dioxahexacyclo[17.3.3.0¹,¹⁸.0²,¹⁵.0⁵,¹⁴.0⁷,¹²]pentacosa-7,9,11-trien-20-one

(1s,2r,5s,14s,15r,18r,19s)-10-hydroxy-5,15,19-trimethyl-6,21-dioxahexacyclo[17.3.3.0¹,¹⁸.0²,¹⁵.0⁵,¹⁴.0⁷,¹²]pentacosa-7,9,11-trien-20-one

C26H34O4 (410.2457)


   

(1r,2r,4r,5z,12r,13r,16z)-13-hydroxy-11,22-diazapentacyclo[11.11.2.1²,²².0²,¹².0⁴,¹¹]heptacosa-5,16,25-triene-25-carbaldehyde

(1r,2r,4r,5z,12r,13r,16z)-13-hydroxy-11,22-diazapentacyclo[11.11.2.1²,²².0²,¹².0⁴,¹¹]heptacosa-5,16,25-triene-25-carbaldehyde

C26H38N2O2 (410.2933)


   

1-isopropyl-4-methylcyclohex-3-en-1-yl 4-hydroxy-3,5-bis(3-methylbut-2-en-1-yl)benzoate

1-isopropyl-4-methylcyclohex-3-en-1-yl 4-hydroxy-3,5-bis(3-methylbut-2-en-1-yl)benzoate

C27H38O3 (410.2821)


   

(2s)-2-[(3e,6e,8s)-8-hydroxy-4,8,12-trimethyltrideca-3,6,11-trien-1-yl]-2,8-dimethylchromen-6-ol

(2s)-2-[(3e,6e,8s)-8-hydroxy-4,8,12-trimethyltrideca-3,6,11-trien-1-yl]-2,8-dimethylchromen-6-ol

C27H38O3 (410.2821)


   

(13z)-2-oxatricyclo[20.2.2.1³,⁷]heptacosa-1(24),3,5,7(27),13,22,25-heptaene-5,24,25-triol

(13z)-2-oxatricyclo[20.2.2.1³,⁷]heptacosa-1(24),3,5,7(27),13,22,25-heptaene-5,24,25-triol

C26H34O4 (410.2457)


   

2,6,7-trimethyl-2-(4,8,12-trimethyltrideca-3,7,11-trien-1-yl)-3,4-dihydro-1-benzopyran-8-ol

2,6,7-trimethyl-2-(4,8,12-trimethyltrideca-3,7,11-trien-1-yl)-3,4-dihydro-1-benzopyran-8-ol

C28H42O2 (410.3185)


   

(5z,8z,11z,14z,17z)-1-(2,4,6-trihydroxyphenyl)icosa-5,8,11,14,17-pentaen-1-one

(5z,8z,11z,14z,17z)-1-(2,4,6-trihydroxyphenyl)icosa-5,8,11,14,17-pentaen-1-one

C26H34O4 (410.2457)


   

3-[(2e,6e)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,6-dien-1-yl]-4-hydroxybenzoic acid

3-[(2e,6e)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,6-dien-1-yl]-4-hydroxybenzoic acid

C27H38O3 (410.2821)


   

(4as,4br,8as,9r,10ar)-2-(3-hydroxy-4-methylphenyl)-4b,8,8,10a-tetramethyl-4,4a,5,6,7,8a,9,10-octahydro-1h-phenanthren-9-yl acetate

(4as,4br,8as,9r,10ar)-2-(3-hydroxy-4-methylphenyl)-4b,8,8,10a-tetramethyl-4,4a,5,6,7,8a,9,10-octahydro-1h-phenanthren-9-yl acetate

C27H38O3 (410.2821)


   

10-(6-hydroxy-2,8-dimethyl-3,4-dihydro-1-benzopyran-2-yl)-3,7-dimethyl-2-(2-methylprop-1-en-1-yl)deca-2,7-dienal

10-(6-hydroxy-2,8-dimethyl-3,4-dihydro-1-benzopyran-2-yl)-3,7-dimethyl-2-(2-methylprop-1-en-1-yl)deca-2,7-dienal

C27H38O3 (410.2821)


   

(5s)-5-[(1s,3ar,3br,5ar,9ar,9bs,11ar)-3a,3b,6,6,9a-pentamethyl-7-oxo-1h,2h,3h,4h,5h,5ah,9bh,10h,11h,11ah-cyclopenta[a]phenanthren-1-yl]-5-methylfuran-2-one

(5s)-5-[(1s,3ar,3br,5ar,9ar,9bs,11ar)-3a,3b,6,6,9a-pentamethyl-7-oxo-1h,2h,3h,4h,5h,5ah,9bh,10h,11h,11ah-cyclopenta[a]phenanthren-1-yl]-5-methylfuran-2-one

C27H38O3 (410.2821)


   

methyl (2z)-5-[(1s,2r,4as,6s,7r,8as)-7-(acetyloxy)-1,6-dihydroxy-2,5,5,8a-tetramethyl-hexahydro-2h-naphthalen-1-yl]-3-methylpent-2-enoate

methyl (2z)-5-[(1s,2r,4as,6s,7r,8as)-7-(acetyloxy)-1,6-dihydroxy-2,5,5,8a-tetramethyl-hexahydro-2h-naphthalen-1-yl]-3-methylpent-2-enoate

C23H38O6 (410.2668)


   

2-[(2e,6e,9r,10e)-9-hydroxy-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraen-1-yl]-5-methylcyclohexa-2,5-diene-1,4-dione

2-[(2e,6e,9r,10e)-9-hydroxy-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraen-1-yl]-5-methylcyclohexa-2,5-diene-1,4-dione

C27H38O3 (410.2821)


   

(1s,2s,4ar,8as)-2-isopropyl-4a-methyl-8-methylidene-octahydronaphthalen-1-yl (2z)-3-[4-(acetyloxy)phenyl]prop-2-enoate

(1s,2s,4ar,8as)-2-isopropyl-4a-methyl-8-methylidene-octahydronaphthalen-1-yl (2z)-3-[4-(acetyloxy)phenyl]prop-2-enoate

C26H34O4 (410.2457)


   

(1r,3ar,5as,9ar,9br,11ar)-1-[(2r,3e,5r)-5,6-dimethylhept-3-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,5ah,6h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-5,7-dione

(1r,3ar,5as,9ar,9br,11ar)-1-[(2r,3e,5r)-5,6-dimethylhept-3-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,5ah,6h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-5,7-dione

C28H42O2 (410.3185)


   

2-(9-hydroxy-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraen-1-yl)-5-methylcyclohexa-2,5-diene-1,4-dione

2-(9-hydroxy-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraen-1-yl)-5-methylcyclohexa-2,5-diene-1,4-dione

C27H38O3 (410.2821)


   

1-(5,6-dimethylhept-3-en-2-yl)-7-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,6h,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-4-one

1-(5,6-dimethylhept-3-en-2-yl)-7-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,6h,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-4-one

C28H42O2 (410.3185)


   

3-[14-(2,3-dihydroxyphenyl)tetradeca-3,6-dien-1-yl]benzene-1,2-diol

3-[14-(2,3-dihydroxyphenyl)tetradeca-3,6-dien-1-yl]benzene-1,2-diol

C26H34O4 (410.2457)


   

(4e,7e,10e,13e,16e,19e,22e)-octacosa-4,7,10,13,16,19,22-heptaenoic acid

(4e,7e,10e,13e,16e,19e,22e)-octacosa-4,7,10,13,16,19,22-heptaenoic acid

C28H42O2 (410.3185)


   

(6z,9z)-22-(5-formyl-1h-pyrrol-2-yl)docosa-6,9-dienenitrile

(6z,9z)-22-(5-formyl-1h-pyrrol-2-yl)docosa-6,9-dienenitrile

C27H42N2O (410.3297)


   

1-(5,6-dimethylhept-3-en-2-yl)-3b-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one

1-(5,6-dimethylhept-3-en-2-yl)-3b-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one

C28H42O2 (410.3185)


   

(5s)-5-[(3ar,3br,9ar)-3a,3b,6,6,9a-pentamethyl-7-oxo-1h,2h,3h,4h,5h,5ah,9bh,10h,11h,11ah-cyclopenta[a]phenanthren-1-yl]-5-methylfuran-2-one

(5s)-5-[(3ar,3br,9ar)-3a,3b,6,6,9a-pentamethyl-7-oxo-1h,2h,3h,4h,5h,5ah,9bh,10h,11h,11ah-cyclopenta[a]phenanthren-1-yl]-5-methylfuran-2-one

C27H38O3 (410.2821)


   

(2r,3s)-2-[15-(acetyloxy)pentadecyl]-4-methylidene-5-oxooxolane-3-carboxylic acid

(2r,3s)-2-[15-(acetyloxy)pentadecyl]-4-methylidene-5-oxooxolane-3-carboxylic acid

C23H38O6 (410.2668)


   

(3ar,4s,6s,10s,11s,11ar)-10-hydroxy-6,10-dimethyl-3-methylidene-4,11-bis(2-methylpropoxy)-octahydrocyclodeca[b]furan-2,5-dione

(3ar,4s,6s,10s,11s,11ar)-10-hydroxy-6,10-dimethyl-3-methylidene-4,11-bis(2-methylpropoxy)-octahydrocyclodeca[b]furan-2,5-dione

C23H38O6 (410.2668)


   

5-{3a,3b,6,6,9a-pentamethyl-7-oxo-1h,2h,3h,4h,5h,5ah,9bh,10h,11h,11ah-cyclopenta[a]phenanthren-1-yl}-5-methylfuran-2-one

5-{3a,3b,6,6,9a-pentamethyl-7-oxo-1h,2h,3h,4h,5h,5ah,9bh,10h,11h,11ah-cyclopenta[a]phenanthren-1-yl}-5-methylfuran-2-one

C27H38O3 (410.2821)


   

2-hydroxy-5-methyl-3-(3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraen-1-yl)cyclohexa-2,5-diene-1,4-dione

2-hydroxy-5-methyl-3-(3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraen-1-yl)cyclohexa-2,5-diene-1,4-dione

C27H38O3 (410.2821)


   

(2r,5r,7's,9's,13'r)-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosane]-14',17'-dien-16'-one

(2r,5r,7's,9's,13'r)-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosane]-14',17'-dien-16'-one

C27H38O3 (410.2821)


   

10-hydroxy-6,10-dimethyl-3-methylidene-4,11-bis(2-methylpropoxy)-octahydrocyclodeca[b]furan-2,5-dione

10-hydroxy-6,10-dimethyl-3-methylidene-4,11-bis(2-methylpropoxy)-octahydrocyclodeca[b]furan-2,5-dione

C23H38O6 (410.2668)


   

5-[3-(4-hydroxy-2-methoxyphenyl)propyl]-3,4-bis(3-methylbut-2-en-1-yl)benzene-1,2-diol

5-[3-(4-hydroxy-2-methoxyphenyl)propyl]-3,4-bis(3-methylbut-2-en-1-yl)benzene-1,2-diol

C26H34O4 (410.2457)


   

(11z)-tricyclo[20.2.2.0²,⁷]hexacosa-1(24),2,4,6,11,22,25-heptaene-3,5,24,25-tetrol

(11z)-tricyclo[20.2.2.0²,⁷]hexacosa-1(24),2,4,6,11,22,25-heptaene-3,5,24,25-tetrol

C26H34O4 (410.2457)


   

(1r,3s,6s)-6-[(1e,3e,5e,7e,9e,11e,13e)-15-hydroxy-3,7,12-trimethylpentadeca-1,3,5,7,9,11,13-heptaen-1-yl]-1,5,5-trimethyl-7-oxabicyclo[4.1.0]heptan-3-ol

(1r,3s,6s)-6-[(1e,3e,5e,7e,9e,11e,13e)-15-hydroxy-3,7,12-trimethylpentadeca-1,3,5,7,9,11,13-heptaen-1-yl]-1,5,5-trimethyl-7-oxabicyclo[4.1.0]heptan-3-ol

C27H38O3 (410.2821)


   

(4ar,4br,6ar,12as,12br,14ar)-10-hydroxy-1,1,4a,6a,8,12b-hexamethyl-3h,4h,4bh,5h,6h,12h,12ah,13h,14h,14ah-naphtho[2,1-a]xanthen-2-one

(4ar,4br,6ar,12as,12br,14ar)-10-hydroxy-1,1,4a,6a,8,12b-hexamethyl-3h,4h,4bh,5h,6h,12h,12ah,13h,14h,14ah-naphtho[2,1-a]xanthen-2-one

C27H38O3 (410.2821)


   

4,5-dihydroxy-6-methyl-2-({1,1,4,7-tetramethyl-octahydro-1ah-cyclopropa[e]azulen-4-yl}oxy)oxan-3-yl acetate

4,5-dihydroxy-6-methyl-2-({1,1,4,7-tetramethyl-octahydro-1ah-cyclopropa[e]azulen-4-yl}oxy)oxan-3-yl acetate

C23H38O6 (410.2668)


   

(2z,7e)-10-[(2r)-6-hydroxy-2,8-dimethyl-3,4-dihydro-1-benzopyran-2-yl]-3,7-dimethyl-2-(2-methylprop-1-en-1-yl)deca-2,7-dienal

(2z,7e)-10-[(2r)-6-hydroxy-2,8-dimethyl-3,4-dihydro-1-benzopyran-2-yl]-3,7-dimethyl-2-(2-methylprop-1-en-1-yl)deca-2,7-dienal

C27H38O3 (410.2821)